SCT Annual Meeting Presentations & Videos
* Note that only Keynote Lectures and Trial of the Year are available to non-members for 2022 and 2023.
Members can login to view all presentations from recent years.

Discover SCT's Scientific Knowledge-Bank

  3190 Learning Opportunities Found

Merit Cudkowicz
2024 (Boston) Annual Meeting
Curtis Meinert Lecture
Advances in Neurotherapeutics Updates on ALS and NeuroNEXT
Penney Cowan
2024 (Boston) Annual Meeting
Founders Lecture
Perspective of Those With Lived Experience: Involving a Patient in Clinical Trials
Adam Devall
2024 (Boston) Annual Meeting
Trial of the Year Award
Randomized Trial of Early Detection and Treatment of Postpartum Hemorrhage
Alan T. Tita
2023 (Baltimore) Annual Meeting
Trial of the Year Award
The Chronic Hypertension and Pregnancy Treatment Trial (CHAP)
Kirsten Bibbins-Domingo
2023 (Baltimore) Annual Meeting
Founders Lecture
Medical Publishing in Dynamic Times: A View from JAMA and the JAMA Network
John P.A. Ioannidis
2023 (Baltimore) Annual Meeting
Curtis Meinert Lecture
Meta-epidemiology of evidence from clinical trials
Dong-Yun Kim
2022 (San Diego) Annual Meeting
Session Proposal
All for One, One for All: How to Run Multiple Networks of COVID-19 Clinical Trials on a Common Platform Using Bayesian Method
Susan Ellenberg
2022 (San Diego) Annual Meeting
Session Proposal
Clinical Trials of COVID-19 Vaccines: Overcoming the Challenges
Min Zhan
2022 (San Diego) Annual Meeting
Contributed Session
Analysis of Adverse Event and Serious Adverse Event Data from Randomized Controlled Trials
Riaz Qureshi
2022 (San Diego) Annual Meeting
Contributed Session
Data Visualization Approaches to Presenting Harms in Clinical Trials
Marie Kay
2022 (San Diego) Annual Meeting
Contributed Session
Assessment of a Risk-Based Quality Management Approach to Protocol Deviations - A Data Coordinating Center's Experience
Eric Fischer
2022 (San Diego) Annual Meeting
Contributed Session
Dynamically Generating Study Monitoring Reports via Email
J Athene Lane
2022 (San Diego) Annual Meeting
Contributed Session
Virtual Clinical Outcome Ascertainment in a Prostate Cancer Treatment Trial
Kelly Karavolos
2022 (San Diego) Annual Meeting
Contributed Session
Challenges of Data Collection for a Fully Remote Clinical Trial with a Multi-Component Outcome: Virtual ELM Pilot Study
Rebecca Metcalfe
2022 (San Diego) Annual Meeting
Contributed Session
Integrating Patient Values into Clinical Trials Using a Patient-Centered Composite Endpoint: A Case Study Using the Control of Hypertension in Pregnancy Study (CHIPS) Trial
BeiBei Guo
2022 (San Diego) Annual Meeting
Contributed Session
A Biomarker-Based Dose-Finding Design for Immunotherapy
Yunshan Duan
2022 (San Diego) Annual Meeting
Contributed Session
A Unified Decision Framework for Phase I Dose-Finding Designs
Hakim-Moulay Dehbi
2022 (San Diego) Annual Meeting
Contributed Session
Early Phase Dose-Finding Trials in Virology
Evan Bagley
2022 (San Diego) Annual Meeting
Contributed Session
Dose-Finding Based on Feasibility and Late-Onset Toxicity in Adoptive Cell Therapy Trials
Jack Wolf
2022 (San Diego) Annual Meeting
Contributed Session
A Permutation Procedure to Detect Heterogeneous Treatments Effects in Randomized Clinical Trials While Controlling the Type-I Error Rate
Peter Godolphin
2022 (San Diego) Annual Meeting
Contributed Session
Estimating Interactions and Subgroup-Specific Treatment Effects in Meta-Analysis Without Aggregation Bias: A Within-Trial Framework
Jiyang Wen
2022 (San Diego) Annual Meeting
Contributed Session
Simultaneous Hypothesis Testing for Multiple Competing Risks in Comparative Clinical Trials
Andrea Viecelli
2022 (San Diego) Annual Meeting
Contributed Session
Enhancing Patient-Partnership in Clinical Trials
Mithat Gönen
2022 (San Diego) Annual Meeting
Special Presentation
Annual Business Meeting 2022
Chalmers & Green Award Presentations
2022 (San Diego) Annual Meeting
Award Presentation
Andrea Viecelli, Jiyang Wen, Peter Godolphin, Jack Wolf
Class of 2022 Fellows
2022 (San Diego) Annual Meeting
Fellows Presentation
Thomas Cook & Alexia Iasonos
Drs. Edward Mills & Gilmar Reis
2022 (San Diego) Annual Meeting
Trial of the Year Award
The TOGETHER Trial: An Adaptive Platform International Trial
Dr. Robert Califf, FDA Commissioner
2022 (San Diego) Annual Meeting
Founders Lecture
The Time is Now to Fix the Evidence Generation System
Mithat Gönen
2022 (San Diego) Annual Meeting
Presidential Welcome
Dr. Worta McCaskill-Stevens
2022 (San Diego) Annual Meeting
Curtis Meinert Lecture
Lessons Learned From the National Cancer Institute's Community Based Clinical Trials
Arsenio Paez
2022 (San Diego) Annual Meeting
Contributed Session
The Effects of Preceding Prospective Collaborative Studies (IDEAL Stage 2b) on the Quality and Impact of Subsequent Randomized Controlled Trials (IDEAL Stage 3) Evaluating Surgical Innovations: A Systematic Review and Case-Control Study
Annabelle South
2022 (San Diego) Annual Meeting
Contributed Session
Communicating Overall Results to Trial Participants: The Perspective of Site Staff from the Show RESPECT Study
Christin Hoffmann
2022 (San Diego) Annual Meeting
Contributed Session
A Core Information Set to Guide Early Phase Surgical Research
Annabelle South
2022 (San Diego) Annual Meeting
Contributed Session
Effectiveness of Interventions to Share Trial Results with Health Workers and Policymakers: Results of a Systematic Review
Zhibao Mi
2022 (San Diego) Annual Meeting
Contributed Session
Statistical Assessment of Unplanned Crossover Effect in Surgical Trials
Jun Yin
2022 (San Diego) Annual Meeting
Contributed Session
Multi-Arm Multi-Outcome Clinical Trial Design and Analysis with Bayesian Spike-and-Slab Priors
Daniel Schwartz
2022 (San Diego) Annual Meeting
Contributed Session
Dynamic Borrowing from Historical Controls via the Synthetic Prior with Covariates in Randomized Clinical Trials
Samuel Sarkodie
2022 (San Diego) Annual Meeting
Contributed Session
A Hybrid Approach to Comparing Parallel-Group and Stepped-Wedge Cluster Randomized Trials When There is Uncertainty in the Intra-Cluster Correlation
Clement Ma
2022 (San Diego) Annual Meeting
Contributed Session
Landscape of Phase 2 Trials in Alzheimer’s Disease: A Systematic Review of Trial Characteristics
Christin Hoffmann
2022 (San Diego) Annual Meeting
Contributed Session
Modifications to Surgical Procedures: A Scoping Review and Preliminary Framework to Promote Transparent Reporting and Efficient Sharing
Chengwu Yang
2022 (San Diego) Annual Meeting
Contributed Session
The CREID: Complementary Randomized Controlled Trial and Real-World Study for Efficacy, Effectiveness, and Implementation Design, with Illustrations of One Published and Two Proposed Large Studies for Sequential and Parallel Designs
Mark Harrison
2022 (San Diego) Annual Meeting
Contributed Session
Involving Patients in the Design of Randomized Clinical Trials
Caitlin Thomas
2022 (San Diego) Annual Meeting
Contributed Session
Predicting Patients’ Willingness to Participate in Clinical Trials: A Simulation Tool Using Patient Choice Data
Yun Qing
2022 (San Diego) Annual Meeting
Contributed Session
A Bayesian Piecewise Exponential Phase II Design for Monitoring a Time-to-Event Endpoint
Yongming Qu
2022 (San Diego) Annual Meeting
Contributed Session
Collection of Precise Reasons for Treatment Discontinuations to Allow Better Defining Estimands
Mayumi Fukuda-Doi
2022 (San Diego) Annual Meeting
Contributed Session
Developing At-A-Glance Workflows for Conducting Trials in Compliance with Complex Regulatory Systems and Expectations for Simplification of the System in Japan
Hongli Li
2022 (San Diego) Annual Meeting
Contributed Session
A Non-Factorial Analysis of a Factorial Phase II Trial Design to Evaluate Single Agent and Combination Consolidation Therapies Following CD19 CAR T-cell Therapy for Relapsed/Refractory Diffuse Large B cell Lymphoma (R/R DLBCL): SWOG-S2114
Fei Yuan
2022 (San Diego) Annual Meeting
Contributed Session
Stopping Rules of Interim Monitoring Analyses in Clinical Trials
Christin Hoffmann
2022 (San Diego) Annual Meeting
Contributed Session
Automated Real-Time Monitoring and Feedback of Shared Decision Making for Surgery: A Non-Randomised Feasibility Study
Fernando Santos Sanchez
2022 (San Diego) Annual Meeting
Contributed Session
A Novel Approach Employing Readability Metrics and Crowdsourcing to Improve Randomised Clinical Trial Information Leaflets
Yongxi Long
2022 (San Diego) Annual Meeting
Contributed Session
A Bayesian Exact Adaptive Platform Design with Continual Reassessment for Trials Utilizing Real World Data
Oleksandr Savenkov
2022 (San Diego) Annual Meeting
Contributed Session
A Comprehensive Simulation Study to Compare Estimators of Restricted Mean Survival Time Using Data from Clinical Trials
Cristina Murray-Krezan
2022 (San Diego) Annual Meeting
Contributed Session
A Culturally and Contextually Situated Multimedia Approach to Recruiting, Consenting, and Randomizing a Hard-to-Reach Spanish-Speaking Population for a Randomized Controlled Trial
Chris Cook
2022 (San Diego) Annual Meeting
Contributed Session
A More Efficient Approach to Clinical Trial Data Collection: The SWOG-nCartes Pilot Collaboration
Gabrielle Murashova
2022 (San Diego) Annual Meeting
Session Proposal
A Partnership between Clinical Safety and Statistics for Aggregate Safety Assessment –Year Two
Letitia Perdue
2022 (San Diego) Annual Meeting
Session Proposal
A Pragmatic Path to Direct Delivery of Drug to Participants
Sasha Kravets
2022 (San Diego) Annual Meeting
Contributed Session
A RSHINY APPLET for Sequential, Multiple Assignment, Randomized Trials with a Time-to-Event Final Endpoint
Ying Zhang
2022 (San Diego) Annual Meeting
Contributed Session
A SAS Macro for the Power of Generalized Estimating Equations Analysis of Cluster Randomized Trials with the Application to Stepped Wedge Designs
Evan Kwiatkowski
2022 (San Diego) Annual Meeting
Contributed Session
A Structured Framework for Adaptively Incorporating External Evidence in Sequentially Monitored Clinical Trials
Zhuopei Hu
2022 (San Diego) Annual Meeting
Contributed Session
A Web Application Tool for Power Calculation of Stepped Wedge Cluster Randomization Trials with Complete/Incomplete Design
Kimberly Carlson
2022 (San Diego) Annual Meeting
Session Proposal
Accommodating “History Effects” in Long Duration, Multi-Site Clinical Trials to Ensure Relevant and Compelling Evidence
Shun Fu Lee
2022 (San Diego) Annual Meeting
Contributed Session
Accounting for Correlation Among the Total Events of Composite Outcomes in Cardiovascular Trials
Richard Emsley
2022 (San Diego) Annual Meeting
Contributed Session
Accounting for Differential Uptake of Treatment-as-Usual in Open-Label RCTs: A Comparison of Methods and Illustration in Mental Health Trials
Guangyu Tong
2022 (San Diego) Annual Meeting
Contributed Session
Accounting for Unequal Cluster Sizes in Designing Cluster Randomized Trials to Detect Treatment Effect Heterogeneity
Marcus Johnson
2022 (San Diego) Annual Meeting
Contributed Session
Addressing Challenges and Barriers to Rural Veteran Participation in Clinical Research Within the Veterans Affairs Healthcare System
Richard Henry
2022 (San Diego) Annual Meeting
Contributed Session
Advantages, Disadvantages, and Other Considerations for Trials in Cohorts: A Decade In
David Zahrieh
2022 (San Diego) Annual Meeting
Contributed Session
Allowing for Uncertainty in the Components Required for Sample Size Estimation for a Cluster Randomized Trial Using the Symbolic Two-Step Method
Richard Emsley
2022 (San Diego) Annual Meeting
Session Proposal
Analysing Clinical Trials Disrupted by the COVID-19 Pandemic
Lu Mao
2022 (San Diego) Annual Meeting
Session Proposal
Analysis of Complex Time-to-Event Endpoints in Clinical Trials
Tyler Bonnett
2022 (San Diego) Annual Meeting
Session Proposal
Bad Bugs in Tough Places – Developing Capacity to Obtain Compelling Evidence in Challenging Environments
Travis Lilley
2022 (San Diego) Annual Meeting
Contributed Session
Bayesian Analysis of Cluster Randomized Trials with Ordinal Endpoints
Fang Fang
2022 (San Diego) Annual Meeting
Contributed Session
Bayesian Methods to Compare Dose Levels to Placebo in a small n, Sequential, Multiple Assignment, Randomized Trial (snSMART) with a Continuous Outcome
Azzolina Danila
2022 (San Diego) Annual Meeting
Contributed Session
Bayesian Network Enforced Super Learner Treatment Effect Estimation in Clinical Trial: A Proposal and Application
Lianlian Du
2022 (San Diego) Annual Meeting
Contributed Session
Bayesian Random Change Point Mixed Model Analysis of Cognitive Performance Trajectories to Identify Eligible Patients for Randomized Clinical Trials
Anda Dragomir
2022 (San Diego) Annual Meeting
Educational Session
Behavioural Trial Design: Using Stakeholder-Driven Processes to Develop Interventions and Assessment Tools Using a Public Health Intervention Example
Menelaos Konstantinidis
2022 (San Diego) Annual Meeting
Contributed Session
Benefits and Pitfalls of Combining Observational and Experimental Studies in Network Meta-Analyses: Implications for Public Health Policy
Paola Berchialla
2022 (San Diego) Annual Meeting
Contributed Session
Benefits and Risks in Leveraging Historical Control Data in Clinical Trials
Ileana Baldi
2022 (San Diego) Annual Meeting
Contributed Session
Building Infrastructure to Exploit Evidence from Patient Preference Information (PPI) Studies
Chuck Huber
2022 (San Diego) Annual Meeting
Educational Session
Causal Inference for Complex Data
Danielle Edwards
2022 (San Diego) Annual Meeting
Contributed Session
Challenges for Conducting Mediation Analyses in Multi-Arm Trials
Elizabeth Avery
2022 (San Diego) Annual Meeting
Contributed Session
Challenges Implementing a Clustered Randomized Behavioral Clinical Trial in a Community Based Participatory Research Framework
Kevin Buhr
2022 (San Diego) Annual Meeting
Educational Session
Clinical Trial Data Monitoring Committees and Reporting Statistical Centers: The Basics and Emerging Issues
Marcus Johnson
2022 (San Diego) Annual Meeting
Contributed Session
Clinical Trial Facilitators: A Novel Approach to Support the Execution of Clinical Research at the Study Site Level
Wendy Seiferheld
2022 (San Diego) Annual Meeting
Contributed Session
ClinicalTrials.gov Tracking with Do-It-Yourself Application Programming Interface (DIY API)
Anca Chis Ster
2022 (San Diego) Annual Meeting
Contributed Session
Combining Non-Adherence and Mediation in a Unified Causal Analysis: A Methodological Review and Application to the AVATAR Trial
Heng Zhou
2022 (San Diego) Annual Meeting
Session Proposal
Complex Innovative Design in the Modern Drug Development Era
Victoria Shepherd
2022 (San Diego) Annual Meeting
Contributed Session
Conceptualising ‘Good’ Proxy Consent Decisions for Clinical Trial Participation: Implications for the Development of Interventions to Improve the Quality of Proxy Consent
Hayley Belli
2022 (San Diego) Annual Meeting
Contributed Session
Considerations When Collecting Real World Data in Expanded Access Programs
Christina Bucci-Rechtweg
2022 (San Diego) Annual Meeting
Contributed Session
Correcting Disparities In Adolescent Access To Medicines By Promoting Age-Inclusive Research
Andrew Hall
2022 (San Diego) Annual Meeting
Contributed Session
Decision making under uncertainty in PI-II dose finding trials in Oncology
Jody Ciolino
2022 (San Diego) Annual Meeting
Educational Session
Demystifying Statistics in Clinical Trials
Fan Li
2022 (San Diego) Annual Meeting
Session Proposal
Design and Analysis of Stepped Wedge Cluster Randomized Trials Based on Marginal Models for Discrete and Continuous Outcomes
Sheng luo
2022 (San Diego) Annual Meeting
Educational Session
Design Clinical Trials with Non-Inferiority Hypothesis: Methods and Applications
Jonathan Beall
2022 (San Diego) Annual Meeting
Session Proposal
Developing Adaptive Trial Designs: A Collaborative Process Balancing Statistical Efficiency with Clinical Importance
Harry Parr
2022 (San Diego) Annual Meeting
Contributed Session
Developing and Externally Validating Clinical Dynamic Prediction Joint Models for Localised Prostate Cancer
Victoria Shepherd
2022 (San Diego) Annual Meeting
Contributed Session
Development of a Core Outcome Set for the Evaluation of Interventions to Enhance Proxy Consent Decisions on Behalf of Adults who Lack Capacity to Consent: A Mixed Methods Study (COnSiDER Study)
Mat Makowski
2022 (San Diego) Annual Meeting
Contributed Session
Disseminating Phase I Vaccine Trial Data in a Pandemic to Inform the Scientific Community – mRNA-1273 Phase I Trials
Shawn Hirsch
2022 (San Diego) Annual Meeting
Contributed Session
Do Participants Exhibit Evidence of Respondent Fatigue After Completion of Subjective Questionnaires Multiple Times Across a Study?: Examination of Data from a Phase I Inpatient Randomized Clinical Trial
Kentaro Takeda
2022 (San Diego) Annual Meeting
Session Proposal
Dose Optimization in Oncology: Why, When and How
Lauren Shirley
2022 (San Diego) Annual Meeting
Contributed Session
Dotting Your I's and Crossing Your T's: An Informed Consent Documentation Tool for Clinical Trials
Yves Rosenberg
2022 (San Diego) Annual Meeting
Educational Session
Essentials of Clinical Trials
Chia-Rui (Jerry) Chang
2022 (San Diego) Annual Meeting
Contributed Session
Estimating Marginal Treatment Effect in Cluster Randomized Trials with Multilevel Missing Outcomes
Wenjing Meng
2022 (San Diego) Annual Meeting
Contributed Session
Estimating the Impact of Patient Preference in Two-Stage Clinical Trials for Binary Outcomes When Some Patients are Indifferent to Treatment
Richard Emsley
2022 (San Diego) Annual Meeting
Contributed Session
Estimation of personalised treatment recommendations in the survival context using a restricted mean survival time outcome
Emily Roberts
2022 (San Diego) Annual Meeting
Contributed Session
Evaluating Intermediate Clinical Endpoints for Futility Analysis in Clinical Trials
Christina Bucci-Rechtweg
2022 (San Diego) Annual Meeting
Contributed Session
Grownish: How And When To Include Adolescents In Adult Research
Katie Mellor
2022 (San Diego) Annual Meeting
Contributed Session
How are Progression Decisions Made Following External Randomised Pilot Trials? A Qualitative Interview Study and Framework Analysis
Peyton Kline
2022 (San Diego) Annual Meeting
Session Proposal
How Different Communication Pathways Impact the Success of a Clinical Trial, A Multifaceted Perspective
Nick Beckley-Hoelscher
2022 (San Diego) Annual Meeting
Contributed Session
How Much is that Data in the Window? A Comparison of Strategies for Analysing Data Recorded Outside Pre-Specified Visit Windows in Randomised Controlled Trials
Lisa Eckstein
2022 (San Diego) Annual Meeting
Contributed Session
Identifying and Examining Ethical Considerations Facing Data Monitoring Committees
Minji Lee
2022 (San Diego) Annual Meeting
Contributed Session
Identifying Meaningful Change on PROMIS Short Forms in Cancer Patients: A Comparison of Item Response Theory and Classic Test Theory Frameworks
Adam Resnick
2022 (San Diego) Annual Meeting
Contributed Session
Implementation of Platform-Enabled Fast Healthcare Interoperability Resources on Behalf of Empowered, Accelerated Discovery in Children with SARS-CoV-2 Infections
Heidi Krause-Steinrauf
2022 (San Diego) Annual Meeting
Contributed Session
Implementation of Substudies in Multi-Center Clinical Trials: The Grade Study Experience
Danielle Edwards
2022 (San Diego) Annual Meeting
Contributed Session
Implementing Personalised Treatment Recommendations to Determine Optimal Treatment Decisions Using Data from a Three-Arm Trial When Both Active Treatments Show Positive Results
Emily Dressler
2022 (San Diego) Annual Meeting
Session Proposal
Improving Data Quality in Multi-Center Trials: Innovative Approaches Utilized within the Wake Forest NCI Community Oncology Research Program Research Base (WF NCORP RB)
Michael Rosenblum
2022 (San Diego) Annual Meeting
Educational Session
Improving Precision and Power in Randomized Trials by Leveraging Baseline Variables
Katie Mellor
2022 (San Diego) Annual Meeting
Contributed Session
Inclusion of Progression Criteria in External Randomised Pilot Trial Funding Applications Submitted to UK NIHR Research for Patient Benefit
Allyn Bove
2022 (San Diego) Annual Meeting
Session Proposal
Inclusive Recruitment Strategies in Clinical Trials: Insights from Rehabilitation Research
Emine Bayman
2022 (San Diego) Annual Meeting
Contributed Session
Increasing the Generalizability of Pain Study Results
Kathryn Hefner
2022 (San Diego) Annual Meeting
Session Proposal
Innovative Approaches to Data Collection Needs in Clinical Trials: Considerations, Lessons Learned and Future Directions
Julie Croft
2022 (San Diego) Annual Meeting
Contributed Session
Integration of Qualitative Research Into Surgical Trials to Optimise Trial Conduct and Understanding of the Trial Results For Maximal Impact
Anna Bosse
2022 (San Diego) Annual Meeting
Contributed Session
Interim Data Communication Strategies for Adaptive Clinical Trial Designs
Jonathan Beall
2022 (San Diego) Annual Meeting
Contributed Session
Interpreting a Bayesian Phase II Futility Clinical Trial
Abigail Baldridge
2022 (San Diego) Annual Meeting
Educational Session
Introduction to Efficient Preparation, Access, and Sharing of Trial Data in REDCap Using the API
Laura Lovato
2022 (San Diego) Annual Meeting
Educational Session
It Takes a Village: Multi-Disciplinary Approach to Designing Stellar Data Collection Forms
Kathryn Arnold
2022 (San Diego) Annual Meeting
Contributed Session
Lessons from Implementing Practice-Level Cluster Randomized Studies within the NCORP Setting
Danielle Cunio
2022 (San Diego) Annual Meeting
Contributed Session
Letter Tracking System Design: The Systolic Blood Pressure Intervention Trial Mind 2020
Katelyn Garcia
2022 (San Diego) Annual Meeting
Contributed Session
Lifestyle Intervention Delivery During the COVID Era
Wei Wei
2022 (San Diego) Annual Meeting
Contributed Session
Local Multisource-Exchangeability Model for Adaptive Information Borrowing from Multiple Historical Controls
Mary Ryan
2022 (San Diego) Annual Meeting
Contributed Session
Maximin Optimal Cluster Randomized Designs Accounting for Treatment Effect Heterogeneity
Ying Yuan
2022 (San Diego) Annual Meeting
Educational Session
Model-Assisted Designs: Make Adaptive Clinical Trials Easy and Accessible
Aditya Pabba
2022 (San Diego) Annual Meeting
Contributed Session
Novel Method of Using JavaScript Encoding and QR (Quick Response) Codes in Remotely Managed Randomization of Blinded Studies in Low-Resource Environments
Eleanor McFadden
2022 (San Diego) Annual Meeting
Contributed Session
OlympiA – A Complex but Successful Model for a Large Global Trial
Bingkai Wang
2022 (San Diego) Annual Meeting
Contributed Session
On the Robustness and Precision of Mixed-Model Analysis of Covariance in Cluster-Randomized Trials
Shaun Bulsara
2022 (San Diego) Annual Meeting
Contributed Session
OnCore and REDCap: A Comparison of Two Data Management Systems
Brian Neumann
2022 (San Diego) Annual Meeting
Contributed Session
One Line on a Manuscript: Operationalizing Ecological Momentary Assessment (EMA) in Clinical Trials
Andrea Arfe
2022 (San Diego) Annual Meeting
Contributed Session
Optimality of Testing Procedures for Survival Data in the Non-Proportional Hazards Setting
Brigitte Voisard
2022 (San Diego) Annual Meeting
Contributed Session
Optimization of a Training Program in Motivational Communication: Phase 1
Pam Mangat
2022 (San Diego) Annual Meeting
Session Proposal
Optimizing Precision Medicine Cancer Clinical Trials
Roger Lewis
2022 (San Diego) Annual Meeting
Session Proposal
Optimizing the Interdisciplinary Design of Adaptive Platform Trials
Audinga-Dea Hazewinkel
2022 (San Diego) Annual Meeting
Contributed Session
Outcome Variance After Dropout as an Indicator of Missing-Not-At-Random Bias in Randomized Clinical Trials
Rachelle Swann
2022 (San Diego) Annual Meeting
Contributed Session
Overview of CDER BIMO Compliance and Enforcement
Daisy Gaunt
2022 (San Diego) Annual Meeting
Contributed Session
Participant Retention in Pediatric Randomized Controlled Trials: Systematic Review and Meta-Analysis
Hayley Belli
2022 (San Diego) Annual Meeting
Session Proposal
Perspectives on Real World Data and Evidence Collection Through Expanded Access
Yisheng Li
2022 (San Diego) Annual Meeting
Session Proposal
Pharmacokinetics and/or Pharmacodynamics-Informed Dose-Finding Designs
Jane Hongyuan Zhang
2022 (San Diego) Annual Meeting
Session Proposal
Planning, Prioritizing, and Conducting Clinical Research in the VA Learning Healthcare System During the COVID-19 Pandemic
Kendra Plourde
2022 (San Diego) Annual Meeting
Contributed Session
Power Analysis for Stepped Wedge Cluster Randomized Trials with Continuous Co-Primary Endpoints
Navneet Hakhu
2022 (San Diego) Annual Meeting
Contributed Session
Quantifying the Impact of Enrichment in Pre-Post Randomized Controlled Clinical Trials
Azzolina Danila
2022 (San Diego) Annual Meeting
Contributed Session
Quantifying the Prior Informativeness via ESS Approach in a Clinical Trial: An Application of a Semiparametric Prior Elicitation Phase IIA Design
Jason Haukoos
2022 (San Diego) Annual Meeting
Contributed Session
Randomization Schemes Using Electronic Health Systems to Facilitate Emergency Department-Based Pragmatic Clinical Trials of Public Health Screening Interventions
Christina Saunders
2022 (San Diego) Annual Meeting
Session Proposal
Real World Experience in Conducting Adaptive Platform Trials
Daisy Gaunt
2022 (San Diego) Annual Meeting
Contributed Session
Retention to pediatric randomized controlled trials during the COVID-19 pandemic: a qualitative study
Laura Levit
2022 (San Diego) Annual Meeting
Session Proposal
Rethinking the Inclusion of Research Biopsies in the Design of Clinical Trials
Songthip Ounpraseuth
2022 (San Diego) Annual Meeting
Contributed Session
Statistical Considerations for Testing Facility Interventions in Infants with Neonatal Opioid Withdrawal Syndrome (NOWS)
Katie Gillies
2022 (San Diego) Annual Meeting
Contributed Session
Strategies to Improve Retention in Randomised Trials: A Cochrane Review
Heidi Krause-Steinrauf
2022 (San Diego) Annual Meeting
Session Proposal
Strategies to Mitigate the Impact of the COVID Pandemic on Trial Implementation, Closeout, Data Quality and Analysis of a Large Multicenter Clinical Trial: The Glycemia Reduction Approaches in Diabetes Comparative Effectiveness Study (GRADE)
Azzolina Danila
2022 (San Diego) Annual Meeting
Contributed Session
SuperLearner Enforced Treatment Effect Estimation in Pediatric Trials
Cherish Boxall
2022 (San Diego) Annual Meeting
Contributed Session
SWAT Priorities to Improve the Evidence to Inform Recruitment and Retention Practice in Clinical Trials
Jieling Miao
2022 (San Diego) Annual Meeting
Contributed Session
The Application of ACCEPT Software in Retrospective Analysis of Specimen Data (SWOG S0500 Translational Medicine Project)
Kim May Lee
2022 (San Diego) Annual Meeting
Contributed Session
The Benefits of Covariate Adjustment for Adaptive Multi-Arm Designs
David Bryde
2022 (San Diego) Annual Meeting
Contributed Session
The CURED Framework: A Data-Driven Management Tool to Aid Successful Delivery of Clinical Research Projects
Corinne McGill
2022 (San Diego) Annual Meeting
Contributed Session
The Effect of Subject Accrual on Futility Analyses in Randomized Clinical Trials with Time-To-Event Endpoints: A Simulation Study on Conditional Power
Xiangrong Kong
2022 (San Diego) Annual Meeting
Session Proposal
The Estimand Framework from the ICH E9(R1) Statistical Principles for Clinical Trials Addendum: Current Implementation Status and Looking Forward
Mollie Payne
2022 (San Diego) Annual Meeting
Contributed Session
The Good, The Bad and The Hidden Bias in Mediation Analyses of Clinical Trials
Ellen Kingsley
2022 (San Diego) Annual Meeting
Contributed Session
The I-SOCIALISE Study: A Cluster Randomised Controlled Trial Investigating the Social Competence and Isolation of Children with Autism Taking Participating in LEGO® Based Therapy (‘Play Brick Therapy’) Groups in Mainstream School Environments
Joseph Rausch
2022 (San Diego) Annual Meeting
Contributed Session
The Inclusion of Covariates in Constrained Longitudinal Data Analysis for Pre-Post Randomized Clinical Trials
John Nichols
2022 (San Diego) Annual Meeting
Contributed Session
The Intervention Portal: Consolidating Study Intervention Tracking with Participant Data Management
Larisa Tereshchenko
2022 (San Diego) Annual Meeting
Educational Session
The Legacy of Tuskegee and Ethics of Clinical Trials
Cory Goldstein
2022 (San Diego) Annual Meeting
Contributed Session
The Problem of Identifying Vulnerable Research Participants in Pragmatic Cluster Randomized Trials
Cody Chiuzan
2022 (San Diego) Annual Meeting
Session Proposal
The Promise and Challenges of Integrating Real-World Evidence in Clinical Research
Julia Collins
2022 (San Diego) Annual Meeting
Contributed Session
The Protocol Review Checklist: A Tool to Ensure Protocol Completeness, Consistency, and Accuracy
Yi Dai
2022 (San Diego) Annual Meeting
Contributed Session
The Use of Evidence-Based Dynamic Treatment Regimes to Improve Depression Outcomes
Katie Gillies
2022 (San Diego) Annual Meeting
Contributed Session
The What, How, When and Who of Sharing Trial Results Summaries with Trial Participants: Stakeholder Informed Guidance from the RECAP Project
Dario Gregori
2022 (San Diego) Annual Meeting
Contributed Session
The Win-Ratio Approach. Some Notes on the Impact of Unbalanced Samples, Heterogeneity, and Clustering in Data
Neil Corrigan
2022 (San Diego) Annual Meeting
Contributed Session
Trial Designs to Target the Conditional Average Treatment Effect, with Application to Operating Surgeon Learning Effects in Surgical RCTS
Lawrence Mbuagbaw
2022 (San Diego) Annual Meeting
Educational Session
TrialTree: A Novel Application for Interactive Trial Design
Jose Luis Olmos- Serrano
2022 (San Diego) Annual Meeting
Contributed Session
TwinRCT: Leveraging External Data, Artificial Intelligence, and Covariate Adjustment
Victoria Shepherd
2022 (San Diego) Annual Meeting
Contributed Session
Unpacking the ‘Black Box of Horrendousness’: A Qualitative Study Exploring the Barriers and Facilitators to Conducting Trials Involving Adults Lacking Capacity to Consent
Tina Neill-Hudson
2022 (San Diego) Annual Meeting
Session Proposal
Using a Single IRB for NIH-Funded Multisite Trials
Maiken Pontoppidan
2022 (San Diego) Annual Meeting
Contributed Session
Using Informational Videos to Support Recruitment for Parenting Trials
Gail Potter
2022 (San Diego) Annual Meeting
Contributed Session
Using Social Contact Data to Improve the Overall Effect Estimate of a Cluster-Randomized Influenza Vaccination Program in Senegal
Heejoon Ahn
2022 (San Diego) Annual Meeting
Contributed Session
Utilization of R Markdown for Automation in Development of Participant Feedback Reports for N-of-1 Trial Designs
Anda Dragomir
2022 (San Diego) Annual Meeting
Contributed Session
Validation of a New Digital Tool to Assess Physician Competency in Behaviour Change Counseling: The Motivational Communication Competency Assessment Test
Mitchell Paukner
2022 (San Diego) Annual Meeting
Contributed Session
Versatile Window Mean Survival Time: Motivating Trial Design and Analysis with Clinical Relevance
Kelly Van Lancker
2022 (San Diego) Annual Meeting
Session Proposal
When and How to Use Covariate Adjustment to Improve Precision in Randomized Trials
Kieran O'Brien
2021 (Virtual) Annual Meeting
Contributed Session
The effect of targeting biannual azithromycin distribution by age group on mortality and resistance in Niger: design of an adaptive cluster-randomized large simple trial (AVENIR)
Emily Rives
2021 (Virtual) Annual Meeting
Contributed Session
Dynamic Scoring and Guided Data Entry in a Tele-Health Cognitive Battery
Gillian Gresham
2021 (Virtual) Annual Meeting
Contributed Session
Evaluating the effect of a mobile audio companion to reduce feelings of distress and loneliness in cancer patients during COVID-19 (COMPANION Trial)
Rachel Phillips
2021 (Virtual) Annual Meeting
Contributed Session
Recommendations for visualising the drug harm profile in Randomised Controlled Trials: a consensus
Zibo Tian
2021 (Virtual) Annual Meeting
Contributed Session
IMPACT OF UNEQUAL CLUSTER SIZES FOR GENERALIZED ESTIMATING EQUATION ANALYSES OF STEPPED WEDGE DESIGNS WITH BINARY OUTCOMES
Lindsay Kehoe
2021 (Virtual) Annual Meeting
Contributed Session
Improving Efficiency by Embedding Trials into Health Care Settings
Shelley Vanderhout
2021 (Virtual) Annual Meeting
Contributed Session
PREVALENCE OF AND FACTORS ASSOCIATED WITH PATIENT-REPORTED OUTCOMES IN PRAGMATIC RANDOMIZED CONTROLLED TRIALS
Min Zhan
2021 (Virtual) Annual Meeting
Contributed Session
CONSIDERATIONS IN IMPLEMENTING THE ESTIMAND FRAMEWORK IN MULTISITE RANDOMIZED CLINICAL TRIALS
Eileen Stock
2021 (Virtual) Annual Meeting
Contributed Session
An Efficient Centralized Statistical Monitoring Program to Improve Data Integrity of Multicenter Clinical Trials
Neal Oden
2021 (Virtual) Annual Meeting
Contributed Session
Number of Strata in Clinical Trial Design and Its Impact on Treatment Imbalance
Monica Taljaard
2021 (Virtual) Annual Meeting
Contributed Session
HOW ARE CLAIMS OF PRAGMATISM JUSTIFIED IN PRIMARY TRIAL REPORTS? RESULTS FROM A REVIEW OF 415 SELF-DECLARED PRAGMATIC TRIALS
Ashley Tjaden
2021 (Virtual) Annual Meeting
Contributed Session
Motivation for participation in a clinical trial among youth and adults with prediabetes or recently diagnosed type 2 diabetes
Jennifer Gassman
2021 (Virtual) Annual Meeting
Contributed Session
Use of Vanguard Enrollment to demonstrate feasibility of a high-enrollment surgical trial: The Safe Cholecystectomy OUTcomes (SCOUT) Clinical Trial of Laparoscopic Cholecystectomy (LC)
Holly Shaw
2021 (Virtual) Annual Meeting
Contributed Session
Centralized Remote and Risk-Based Monitoring in the INVESTED Trial: a Cost-Effective and Easy-to-Implement Approach
Daniele Farrisi
2021 (Virtual) Annual Meeting
Contributed Session
Research Ready: Strategies for Successful Implementation of Research in Clinical Settings
Peter McCulloch
2021 (Virtual) Annual Meeting
Contributed Session
Using IDEAL to evaluate research waste in surgery more realistically.
Harry Parr
2021 (Virtual) Annual Meeting
Contributed Session
DEVELOPING AND VALIDATING CLINICAL DYNAMIC PREDICTION JOINT MODELS TO PREDICT PROGNOSIS IN PROSTATE CANCER PATIENTS
Paola Berchialla
2021 (Virtual) Annual Meeting
Contributed Session
Prediction of treatment outcome and heterogeneous treatment effect in clinical trials: a machine learning approach
Leah Pirondini
2021 (Virtual) Annual Meeting
Contributed Session
Covariate adjustment in cardiovascular randomised controlled trials: a review of current practice and simulation studies
Lara Maleyeff
2021 (Virtual) Annual Meeting
Contributed Session
Estimating treatment effect heterogeneity in stepped wedge cluster randomized trials with binary outcomes
Georgine Price
2021 (Virtual) Annual Meeting
Contributed Session
SITE MONITORING AND SITE MANAGEMENT DURING COVID-19 - A CONTRACT RESEARCH ORGANIZATION’S EXPERIENCE
Mitra Lewis
2021 (Virtual) Annual Meeting
Contributed Session
Electronic Data Capture (EDC) system modifications to capture COVID-19 related data in the National Drug Abuse Treatment Clinical Trial Network (NDAT CTN)
Monica Taljaard
2021 (Virtual) Annual Meeting
Contributed Session
REPORTING OF INFORMED CONSENT IN PRAGMATIC TRIALS: RESULTS FROM A SYSTEMATIC LITERATURE SURVEY
Dario Gregori
2021 (Virtual) Annual Meeting
Contributed Session
The challenge of the COVID-19 pandemic faced by Italian ethics committees: a research survey
Giles Partington
2021 (Virtual) Annual Meeting
Contributed Session
The Design and Analysis of Small Population and Rare Disease Trials: A Review of Randomised Trials
Daniel Schwartz
2021 (Virtual) Annual Meeting
Contributed Session
Fast and Informative Phase 2b Dose-ranging Trials Using Bayesian Uncertainty-Directed Designs with Model Averaging
Emily Roberts
2021 (Virtual) Annual Meeting
Contributed Session
Incorporating Baseline Covariates to Validate Surrogate Endpoints with a Constant Biomarker under Control Arm
Matthew Dodd
2021 (Virtual) Annual Meeting
Contributed Session
STATISTICAL METHODS FOR HANDLING NON-ADHERENCE TO INTERVENTIONS IN RANDOMISED NON-INFERIORITY TRIALS: A SYSTEMATIC REVIEW
Victoria Cornelius
2021 (Virtual) Annual Meeting
Contributed Session
Improving the analysis of adverse event data in randomised controlled trials
Matthew Gooden
2021 (Virtual) Annual Meeting
Contributed Session
Determining the Optimal Percent of Research Records to Review: Reducing the Variability in Audits with Human Research Participants
Sharon Love
2021 (Virtual) Annual Meeting
Contributed Session
Making a distinction between data cleaning and central monitoring
Lara Philipps
2021 (Virtual) Annual Meeting
Contributed Session
Study within a trial comparing electronic versus paper patient reported outcome collection
Diana Papaioannou
2021 (Virtual) Annual Meeting
Contributed Session
Adverse event recording fails to reflect potential harms: A review of trial protocols of behavioural, lifestyle and psychological therapy interventions.
Rebecca Silva
2021 (Virtual) Annual Meeting
Contributed Session
Would the recommended dose have been different using novel dose-finding designs? Comparing dose-finding designs in published trials.
Xueqi Wang
2021 (Virtual) Annual Meeting
Contributed Session
Power considerations for generalized estimating equations analyses of four-level designs
Martin Law
2021 (Virtual) Annual Meeting
Contributed Session
Multi-outcome trials with a generalised number of efficacious outcomes
Katie Mellor
2021 (Virtual) Annual Meeting
Contributed Session
PROGRESSION FROM EXTERNAL PILOT TO DEFINITIVE RANDOMISED CONTROLLED TRIAL ARE NOT ADEQUATELY REPORTED: A METHODOLOGICAL REVIEW OF PROGRESSION CRITERIA REPORTING
Christina Fu
2021 (Virtual) Annual Meeting
Contributed Session
USE OF COMPREHENSIVE SOLICITED EVENT REPORTING FOR SAFETY MONITORING IN CLINICAL TRIALS WITH STANDARD OF CARE DRUGS
Glory Koerbel
2021 (Virtual) Annual Meeting
Contributed Session
HOW CLINICAL TRIAL MANAGEMENT SYSTEMS CAN HELP REDUCE COORDINATOR BURDEN
Zhibao Mi
2021 (Virtual) Annual Meeting
Contributed Session
Role of Electronic Health Records in VA CSP Multicenter Clinical Trials
Gail Potter
2021 (Virtual) Annual Meeting
Contributed Session
Dismantling the Fragility Index: A Demonstration of Statistical Reasoning
Phyllis Goodman
2021 (Virtual) Annual Meeting
Contributed Session
Actions of a National Oncology Group to Manage the Impact of the COVID-19 Pandemic
Menelaos Konstantinidis
2021 (Virtual) Annual Meeting
Contributed Session
MULTI-AGENT AGREEMENT COEFFICIENTS: IMPLICATIONS FOR CLINICAL TRIALS OF DIAGNOSTIC TESTING
Christin Hoffmann
2021 (Virtual) Annual Meeting
Contributed Session
MEASURING INNOVATION-SPECIFIC OUTCOMES IN STUDIES EVALUATING NEW SURGICAL PROCEDURES AND DEVICES: APPRAISAL AND RECOMMENDATION OF OUTCOME MEASUREMENT INSTRUMENTS USING MODIFIED COSMIN METHODOLOGY
Douglas Lammie
2021 (Virtual) Annual Meeting
Contributed Session
Facilitating Study Collaboration in your Pajamas: Replicating a Virtual Office Space While Teleworking"
Stuart Nicholls
2021 (Virtual) Annual Meeting
Contributed Session
THE IMPACT OF PATIENT ENGAGEMENT ON TRIALS AND TRIALISTS: AN INTERVIEW STUDY WITH IMPACT AWARDEES
Gemma Ainsworth
2021 (Virtual) Annual Meeting
Contributed Session
CO-ENROLMENT OF PATIENTS IN TRIALS OF COMPLEX SURGICAL INTERVENTIONS: RECOMMENDATIONS FROM THE INTACT TRIAL
Brian Burke
2021 (Virtual) Annual Meeting
Contributed Session
From Clinical Trial to Observational Study: Long-Term Retention in the TODAY and TODAY2 Studies
Saskia Eddy
2021 (Virtual) Annual Meeting
Contributed Session
HOW BIG SHOULD MY PILOT STUDY BE? A METHODOLOGICAL REVIEW
Ondrej Blaha
2021 (Virtual) Annual Meeting
Contributed Session
A Bayesian Exact Platform Design for Multi-arm, Phase II trials with Historical Control
Kendra Davis-Plourde
2021 (Virtual) Annual Meeting
Contributed Session
Sample size calculation for stepped wedge cluster randomized trials with multiple levels of clustering
Brian Burke
2021 (Virtual) Annual Meeting
Contributed Session
Developing an E-Consent System
Alyssa Vanderbeek
2021 (Virtual) Annual Meeting
Contributed Session
Consequences of Phase I Dose Selection on Go/No-Go Decisions in Oncology Drug Development
Mitchell Paukner
2021 (Virtual) Annual Meeting
Contributed Session
Window Mean Survival Time
J Athene Lane
2021 (Virtual) Annual Meeting
Contributed Session
PATIENT AND PUBLIC INVOLVEMENT IN CLINICAL TRIALS: A MIXED METHODS STUDY IN A CLINICAL TRIALS UNIT TO IDENTIFY GOOD PRACTICE, BARRIERS AND FACILITATORS
Madeleine Clout
2021 (Virtual) Annual Meeting
Contributed Session
Are Electronic Study Management Systems Acceptable to Participating Sites?
Amy Sullivan
2021 (Virtual) Annual Meeting
Contributed Session
What is the (end) point?
Joerg Hasford
2021 (Virtual) Annual Meeting
Contributed Session
There are too many p-values smaller 0.01 for clinically relevant primary endpoints reported in randomised trials - results from a systematic analysis of high impact publications
Dario Gregori
2021 (Virtual) Annual Meeting
Contributed Session
The state-of-the-art of the Prior Elicitation method in clinical trial design and analysis: a literature review
Christopher Schroth
2021 (Virtual) Annual Meeting
Contributed Session
The Record of Study Consultation (RSC): A Tool to Control, Document, & Streamline Sponsor Guidance
Sheila Sprague
2021 (Virtual) Annual Meeting
Contributed Session
THE IMPACT OF COVID-19 RESTRICTIONS ON PARTICIPANT ENROLLMENT IN THE PREPARE TRIAL
Mudathir Ibrahim
2021 (Virtual) Annual Meeting
Contributed Session
The effects of preceding prospective collaborative studies (IDEAL stage 2b) on the quality and impact of subsequent randomized controlled trials (IDEAL stage 3) evaluating surgical innovations. A case-control systematic review of the literature
David Zahrieh
2021 (Virtual) Annual Meeting
Contributed Session
Symbolic two-step method compared with single-step methods to model the center mean outcome in cluster randomized trials
Wei Wei
2021 (Virtual) Annual Meeting
Contributed Session
Summarizing historical information for making go/no go decisions in phase II clinical trials
Subodh Selukar
2021 (Virtual) Annual Meeting
Contributed Session
STRATIFIED RANDOMIZATION FOR PLATFORM TRIALS WITH DIFFERING EXPERIMENTAL ARM ELIGIBILITY
Sasha Kravets
2021 (Virtual) Annual Meeting
Contributed Session
STATISTICAL CONSIDERATIONS FOR SEQUENTIAL, MULTIPLE ASSIGNMENT, RANDOMIZED TRIALS
Leslie Revoredo
2021 (Virtual) Annual Meeting
Contributed Session
Responsible Tracking and Accounting of Participant Mental Health Urgency/Emergency Responses in Substance Use Treatment Clinical Trials
Yuanxi Jia
2021 (Virtual) Annual Meeting
Contributed Session
Redundant Clinical Trials Are Hurting Patients An Example of Randomized Clinical Trials Conducted in mainland China Evaluating Statins among Patients with Coronary Artery Disease
Kimberly Carlson
2021 (Virtual) Annual Meeting
Contributed Session
PTXRx Study: How Pragmatic Trial Design can Inoculate Against Risks to Study Integrity in a Global Pandemic
David Zahrieh
2021 (Virtual) Annual Meeting
Contributed Session
Prediction of participant satisfaction in cancer chemoprevention clinical trials using random forests
Alyssa Vanderbeek
2021 (Virtual) Annual Meeting
Contributed Session
Platform trials take the spotlight in COVID-19
Tao Wang
2021 (Virtual) Annual Meeting
Contributed Session
PHASE I CAR-T CLINICAL TRIALS REVIEW
Christin Hoffmann
2021 (Virtual) Annual Meeting
Contributed Session
A CORE OUTCOME SET FOR STANDARDIZING AND REPORTING SURGICAL INNOVATION: RESULTS OF AN INTERNATIONAL DELPHI SURVEY AND CONSENSUS MEETING
Radhika Kondapaka
2021 (Virtual) Annual Meeting
Contributed Session
LEVERAGING PATIENT PROFILES FOR ROUTINE PHARMACOVIGILANCE IN CLINICAL TRIALS
Sharone Edelstein
2021 (Virtual) Annual Meeting
Contributed Session
Lessons learned from The Restoring Insulin Secretion (RISE) Study: A multi-protocol, multi-center clinical trial in adults and youth with prediabetes and early type 2 diabetes
Danila Azzolina
2021 (Virtual) Annual Meeting
Contributed Session
How informative is informative in small size trials: a simulation study
Victoria Homer
2021 (Virtual) Annual Meeting
Contributed Session
GUIDELINES FOR THE CONTENT OF STATISTICAL ANALYSIS PLANS FOR EARLY PHASE CLINICAL TRIALS
Liyun Jiang
2021 (Virtual) Annual Meeting
Contributed Session
Elastic Priors to Dynamically Borrow Information from Historical Data in Clinical Trials
Kathryn Evans
2021 (Virtual) Annual Meeting
Contributed Session
Discriminant validity of the Misuse, Abuse, and Diversion Drug Event Reporting System (MADDERS) in adult and pediatric phase II and III clinical trials
Kathryn Hefner
2021 (Virtual) Annual Meeting
Contributed Session
Development of a COVID-19 Impact Assessment for National Drug Abuse Treatment (NDAT) Clinical Trials Network (CTN)
Marcus Johnson
2021 (Virtual) Annual Meeting
Contributed Session
Development and Implementation of Work Engagement Strategies in a Clinical Research Consortium During the Coronavirus Disease 2019 (COVID-19) Pandemic
Siyun Yang
2021 (Virtual) Annual Meeting
Contributed Session
Covariate adjustment in subgroup analyses of randomized clinical trials: A propensity score approach
Fei Yuan
2021 (Virtual) Annual Meeting
Contributed Session
Cost-Effectiveness analysis of cardiac versus non-cardiac surgery on cardiovascular-disease population
Xiaoyu Tang
2021 (Virtual) Annual Meeting
Contributed Session
Bayesian multivariate network meta-analysis model for the difference in restricted mean survival times
Andrea Marraffino
2021 (Virtual) Annual Meeting
Contributed Session
Automated, customized, patient-centric performance feedback in clinical trials to improve data accuracy and patient compliance
Shun Fu Lee
2021 (Virtual) Annual Meeting
Contributed Session
Analysis for cluster-randomized crossover trials with multiple periods.
Bryan Nelson
2021 (Virtual) Annual Meeting
Contributed Session
An Examination of Methods for Parameter Estimation Following Adaptive Group Sequential Clinical Trials
Wen Zhang
2021 (Virtual) Annual Meeting
Contributed Session
A Bayesian group sequential design for randomized biosimilar clinical trials with adaptive information borrowing from historical data
Qilu Yu
2021 (Virtual) Annual Meeting
Session Proposal
Managing Pragmatic Clinical Trials in the Time of COVID-19
Zachary Hallinan
2021 (Virtual) Annual Meeting
Educational Session
Accelerating evidence generation through quality by design
Stefan Englert
2021 (Virtual) Annual Meeting
Educational Session
How the estimand addendum to the ICH E9 guideline helps structure clinical objectives, analyses, and conclusions – a series of oncology case studies
Audrey Mauguen
2021 (Virtual) Annual Meeting
Contributed Session
THE TRUE POWER OF CLINICAL TRIALS IN PEDIATRIC CANCERS AND OTHER RARE DISEASES
Lauren Balmert
2021 (Virtual) Annual Meeting
Session Proposal
Operational Innovations in Academic Data Analysis and Coordinating Centers
Thomas Cook
2021 (Virtual) Annual Meeting
Session Proposal
Missing Data in Clinical Trials: principles, planning, prevention
Lehana Thabane
2021 (Virtual) Annual Meeting
Session Proposal
Design and conduct of pilot and feasibility trials: focus on unresolved issues
Rema Raman
2021 (Virtual) Annual Meeting
Session Proposal
Impact of the COVID-19 Pandemic on the Design, Operations and Analysis Plans of Dementia Trials
The RECOVERY Collaborative Group
2021 (Virtual) Annual Meeting
Trial of the Year Award
RECOVERY - Randomised Evaluation of COVID-19 Therapy
Yves Rosenberg
2021 (Virtual) Annual Meeting
Educational Session
Essentials of Clinical Trials
Anna Heath
2021 (Virtual) Annual Meeting
Educational Session
Designing Clinical Research to Inform Decision-Making using Value of Information
Susan Halabi, Domenic Reda, Li Chen, Liz Garrett-Mayer, Mithat Gönen, Colin Begg
2021 (Virtual) Annual Meeting
Special Presentation
Annual Business Meeting 2021
J. Jack Lee, 2021 SCT Fellows
2021 (Virtual) Annual Meeting
Fellows Presentation
Presentation of the Class of 2021 Fellows
Pralay Mukhopadhyay
2021 (Virtual) Annual Meeting
Session Proposal
Challenges with COVID-19 Vaccine Development and Assessing Impact of the Pandemic on Oncology Trial Outcomes
Darren Courtney
2021 (Virtual) Annual Meeting
Session Proposal
Choices, choices: Selecting, defining, and measuring outcomes for young people with depressive disorders
Holly Janes
2021 (Virtual) Annual Meeting
Session Proposal
Current issues in the design and analysis of COVID-19 vaccine efficacy trials
Dee Blumberg
2021 (Virtual) Annual Meeting
Session Proposal
Challenges and Best Practices for Recruitment and Retention During the COVID Pandemic
James Wason
2021 (Virtual) Annual Meeting
Contributed Session
Costs and Staffing Resource Requirements for Adaptive Trials: results from the Costing Adaptive Trials (CAT) Project
Beatriz Goulao
2021 (Virtual) Annual Meeting
Contributed Session
Patient and public involvement in numerical aspects of trials: a theory-informed survey of trialists current practices, barriers and facilitators
Yumin Wang
2021 (Virtual) Annual Meeting
Contributed Session
Design and analysis of partially randomized preference trials with propensity score stratification
Xinyu Tang
2021 (Virtual) Annual Meeting
Contributed Session
The Use of Conditional Power in Vaccine Trials with Seasonal Variations
Laura Levit
2021 (Virtual) Annual Meeting
Session Proposal
It Can Be Done! Equitable, Accessible, and Efficient Clinical Trials Through Streamlined Protocol Designs and Requirements
Chen Hu
2021 (Virtual) Annual Meeting
Session Proposal
recent developments in quantitative benefit-risk assessment in clinical trials
Tyler Bonnett
2021 (Virtual) Annual Meeting
Session Proposal
Design and Implementation of Clinical Trials in a Pandemic – Reflecting on the ACTT Studies
Hayley Belli
2021 (Virtual) Annual Meeting
Contributed Session
Guidelines regarding the enrollment of patients and evidence from Expanded Access programs: A case study of convalescent plasma therapy for the treatment of COVID-19
Alice Faust
2021 (Virtual) Annual Meeting
Contributed Session
Challenges and proposed solutions in making clinical research on COVID-19 ethical. A status quo analysis across German research ethics committees
Jody Ciolino
2021 (Virtual) Annual Meeting
Contributed Session
Making interim decisions using conditional power based on a surrogate endpoint
Arsenio Paez
2021 (Virtual) Annual Meeting
Contributed Session
Intervention fidelity and treatment effect estimates in clinical trials of complex interventions: A meta-epidemiological study.
Susan Halabi
2021 (Virtual) Annual Meeting
Session Proposal
SCT New Committees and DMC Training Initiative
Monica Taljaard
2021 (Virtual) Annual Meeting
Session Proposal
Pragmatic trials: key unresolved ethical issues and the need for guidance
Janel Fedler
2021 (Virtual) Annual Meeting
Session Proposal
The Impact of COVID-19 on the Conduct of Trials in the NeuroNEXT Network
Kert Viele
2021 (Virtual) Annual Meeting
Session Proposal
Bayesian Modeling in COVID-19 – Disease Modeling, Therapeutics, and Vaccines
Julissa Almonte Santana
2021 (Virtual) Annual Meeting
Contributed Session
Web-Based Lab Tracking for Lab Blood Data Collection and Shipping Manifest Creation
Jennifer Le-Rademacher
2021 (Virtual) Annual Meeting
Contributed Session
Adverse Event Burden Score—A Versatile Summary Measure for Cancer Clinical Trials
Susan Halabi
2021 (Virtual) Annual Meeting
Contributed Session
On the Design of Stratified Biomaker Trials with Measurement Error
Subodh R. Selukar, Siyun Yang, Xiaoyu Tang
2021 (Virtual) Annual Meeting
Award Presentation
Thomas C. Chalmers Scholarship Finalists
Lehana Thabane
2021 (Virtual) Annual Meeting
Session Proposal
INCREASING DIVERSITY IN CARDIOVASCULAR CLINICAL TRIALS: ENGAGEMENT, RECRUITMENT, LEADERSHIP
Jonathan Cook
2021 (Virtual) Annual Meeting
Session Proposal
The ASPIRE guidance on surgical placebo controls in randomised trials
Erinn Hade
2021 (Virtual) Annual Meeting
Session Proposal
Sample size re-estimation: Reflections on implementation and extensions to complex designs
Ashley Wegel
2021 (Virtual) Annual Meeting
Session Proposal
Adaptive COVID-19 Treatment Trial (ACTT) Data Management: Ensuring Success in a Constantly-Evolving, High-Demand Pandemic Environment
Sheng Luo
2021 (Virtual) Annual Meeting
Educational Session
Design Clinical Trials with Multiple Endpoints: Methods and Applications
Martin Landray
2021 (Virtual) Annual Meeting
Curtis Meinert Lecture
Better Trials for Better Health
Susan Halabi
2021 (Virtual) Annual Meeting
Educational Session
Biomarker Driven Trials for Precision Medicine
Jody Ciolino, SCT Membership Committee
2021 (Virtual) Annual Meeting
Special Presentation
New Member Welcome & Orientation
Greg Ball
2021 (Virtual) Annual Meeting
Session Proposal
Different Clinical Trial Analyses for Different Stakeholders
Saurabh Mukhopadhyay
2021 (Virtual) Annual Meeting
Session Proposal
Leveraging External Evidence in Clinical Research using Novel Statistical Methods
Shahrul Mt-Isa
2021 (Virtual) Annual Meeting
Session Proposal
Benefit-Risk Assessment in Clinical Trials with Individual Patient Needs in Mind
James Albert
2021 (Virtual) Annual Meeting
Session Proposal
Design and Implementation of a Vaccine Trial in a Pandemic – mRNA-1273 Phase I Trial
Nikki Totton
2021 (Virtual) Annual Meeting
Contributed Session
Utilising Benefit-Risk Assessments within Clinical Trials
Sonia Jain
2021 (Virtual) Annual Meeting
Session Proposal
Design, Implementation, and Analysis of N-of-1 Clinical Trials
Charles Weijer
2021 (Virtual) Annual Meeting
Session Proposal
Ethics and future of human challenge trials with SARS-CoV-2 to speed vaccine development
Cliff Lane
2021 (Virtual) Annual Meeting
Founders Lecture
Conducting Clinical Research in the Setting of an Outbreak: From HIV to Ebola to COVID-19
Dikla Blumberg
2020 (Virtual) Annual Meeting
Session Proposal
Strategies to Collaboratively Manage Protocol Deviations in Multi-Site Clinical Trials
Amy Ruppert Stark
2020 (Virtual) Annual Meeting
Session Proposal
The design and implementation of Master Protocols using examples from oncology clinical trials.
Simon Bacon
2020 (Virtual) Annual Meeting
Session Proposal
Methodological advances in the conduct of behavioral clinical trials: An International Behavioural Trials Network (IBTN) update.
Lu Mao Mao
2020 (Virtual) Annual Meeting
Session Proposal
The win ratio approach to composite endpoints
Brooke Erchinger
2020 (Virtual) Annual Meeting
Educational Session
Using meta-analysis to combine results from clinical trials
Susan Czajkowski
2020 (Virtual) Annual Meeting
Educational Session
From Ideas to Efficacy: Designing & Optimizing Behavioral Treatments for Chronic Diseases
Cody Chiuzan
2020 (Virtual) Annual Meeting
Educational Session
Web-based applications for early-phase trials designs
Michael Rosenblum
2020 (Virtual) Annual Meeting
Session Proposal
Adjusting for Prognostic Baseline Variables to Improve Precision and Power in Randomized Trials
Elizabeth Wright
2020 (Virtual) Annual Meeting
Session Proposal
Management and Sharing of Individual Participant Deidentified Data (IPD)
Andrew Embleton-Thirsk
2020 (Virtual) Annual Meeting
Contributed Session
Contrasting case-studies of non-commercial trials being used as a pivotal evidence in licencing submissions to the European Medicines Agency
Meredith Warshaw
2020 (Virtual) Annual Meeting
Contributed Session
IMPAACT 2016: Interdisciplinary Collaboration at Multiple Levels
Jason Kojtek
2020 (Virtual) Annual Meeting
Contributed Session
Building a drug management system
Susan Halabi, Mithat Gönen
2020 (Virtual) Annual Meeting
Fellows Presentation
Presentation of the Class of 2020 Fellows
Levent Bayman
2020 (Virtual) Annual Meeting
Contributed Session
Real-Time Risk-Based Monitoring in Clinical Trials Using Business Intelligence Tools (Unlikely Companions)
Levent Bayman
2020 (Virtual) Annual Meeting
Contributed Session
Transition From Two Phase 3 Clinical Trials To A Reduced Follow-Up Only Trial
Deborah Zarin
2020 (Virtual) Annual Meeting
Contributed Session
Addressing Challenges in Registering and Reporting Results for Master Protocol Studies
Anna Heath
2020 (Virtual) Annual Meeting
Contributed Session
A Bayesian Continual Reassessment Design for a Dose Ranging Study of Intranasal Dexmedetomidine for Paediatric Laceration Repair
Anna Heath
2020 (Virtual) Annual Meeting
Contributed Session
The KidsCAN-PERC Innovative Paediatric Clinical Trials Network (iPCT): An Interdisciplinary Approach to Clinical Trials Methodology.
Anna Heath
2020 (Virtual) Annual Meeting
Contributed Session
Determining a Bayesian Predictive Power Stopping Rule for Futility in a Non-Inferiority Trial with Binary Outcomes: The INK trial
Chris Rogers
2020 (Virtual) Annual Meeting
Contributed Session
Automation of clinical trial statistical monitoring
Danila Azzolina
2020 (Virtual) Annual Meeting
Contributed Session
Bayesian HPD-based sample sizedetermination using semi-parametric prior elicitation
Daniele Bottigliengo
2020 (Virtual) Annual Meeting
Contributed Session
Central Statistical Data Quality Monitoring in Clinical Studies: an application to the ROLEX registry
Danila Azzolina
2020 (Virtual) Annual Meeting
Contributed Session
Bayesian methods to cope with poor accrual in pediatric trials
Kelly Folkers
2020 (Virtual) Annual Meeting
Contributed Session
Data from Expanded Access: Opportunity for Real World Evidence Collection and Insights?
Fuad Abujarad
2020 (Virtual) Annual Meeting
Contributed Session
Comparing a Multimedia Interactive Virtual Informed Consent (VIC) to Traditional Paper-based Method: A randomized Clinical Trial
Ilaria Domenicano
2020 (Virtual) Annual Meeting
Contributed Session
Determining mental health condition patterns in Veterans with a lifetime PTSD diagnosis
Grecio Sandoval
2020 (Virtual) Annual Meeting
Contributed Session
Cost-Efficient Clinical Studies with Continuous Time-to-Event Outcomes
Jessica Guyer
2020 (Virtual) Annual Meeting
Contributed Session
Clinical Trial Design, Protocol Implementation, and Secular Treatment Trends for Persons Living with HIV and Opioid Use Disorder: Lessons Learned from a National Institute on Drug Abuse Clinical Trials Network (CTN) Trial
Fei Yuan
2020 (Virtual) Annual Meeting
Contributed Session
The Association between Genotypes and Post Cardiac Surgery Bleedings: A substudy of the Steroids in Cardiac Surgery Trial (SIRS)
Lucy Culliford
2020 (Virtual) Annual Meeting
Contributed Session
Do study participants complete electronic questionnaires?
Shray Alag
2020 (Virtual) Annual Meeting
Contributed Session
Extracting Unique Insights by Mining Single Nucleotide Polymorphisms (SNPs) from ClinicalTrials.gov and Applying the Human Phenotype Ontology
Rick Mitchell
2020 (Virtual) Annual Meeting
Contributed Session
Ensuring Consistency Across CDISC Dataset Programming Processes
Daniel Kang
2020 (Virtual) Annual Meeting
Contributed Session
Efficient Bayesian Adaptive Design for Oncology Clinical Trials with Multiple Biomarker Subgroups
Nora Hutchinson
2020 (Virtual) Annual Meeting
Contributed Session
How Many Patients Does It Take to Develop a New Cancer Drug? A Cohort Study of Pre-license Oncology Drugs
Jonathan Walsh
2020 (Virtual) Annual Meeting
Contributed Session
Improving Clinical Trial Efficiency Using Machine Learning Models of Disease Progression
Russell Thirard
2020 (Virtual) Annual Meeting
Contributed Session
Integrating expert opinions with clinical trial data to increase power to detect a treatment effect in subgroups: example of a Bayesian analysis of the VeRDiCT trial
Chris Rogers
2020 (Virtual) Annual Meeting
Contributed Session
Instrumental variable methods for assessing the causal effect of an intervention in the presence of differential non-adherence; application to the AIRWAYS-2 trial
Yuanyuan Lu
2020 (Virtual) Annual Meeting
Contributed Session
How Big is a Big Hazard Ratio in Clinical Trials?
Dikla Blumberg
2020 (Virtual) Annual Meeting
Session Proposal
Regulatory considerations for a multi-site clinical trial treating opioid use disorder (OUD) with vulnerable populations: pregnant women, infants, and potential prisoners
Yue Song
2020 (Virtual) Annual Meeting
Contributed Session
Random-effects meta-analysis of combined outcomes based on reconstructions of individual patient data
Kristina Lindsley
2020 (Virtual) Annual Meeting
Contributed Session
Public availability of clinical trial results from a random sample of systematic reviews
Matthew Gooden
2020 (Virtual) Annual Meeting
Contributed Session
The Impact of Site Initiation Visits on Non Compliance in Neurology Research
Alicia Williams
2020 (Virtual) Annual Meeting
Contributed Session
The Impact of Different Missing Data Imputation Methods: a case study using the Veterans Affairs Nephropathy in Diabetes (VA NEPHRON-D) Study
Alisa Stephens-Shields
2020 (Virtual) Annual Meeting
Contributed Session
Simulation-based Design of Pragmatic Trials in Psoriatic Arthritis Using Propensity Scores
Rouba Chahine
2020 (Virtual) Annual Meeting
Contributed Session
Sample Size Methods for Two-Stage Randomized Trials with Time to Event Data
Isabelle Weir
2020 (Virtual) Annual Meeting
Contributed Session
Counterfactual mediation analysis with multistate models for surrogate and clinical time-to-event outcomes
Victoria Trapani
2020 (Virtual) Annual Meeting
Contributed Session
Vital Status Ascertainment in a Long-Term Clinical Study of Type 1 Diabetes
Wendi Liang
2020 (Virtual) Annual Meeting
Contributed Session
Using Results from a Natural History Study to Reduce Patient Burden in Later Clinical Trials
Phoebe Gauthier
2020 (Virtual) Annual Meeting
Contributed Session
Using an Interdisciplinary Approach to Develop a Medical Record Abstraction and Quality Assurance Process for Generating the Primary Outcome in a Multi-Site Implementation Study
Deborah Profit, PhD
2020 (Virtual) Annual Meeting
Contributed Session
The Value Proposition of eConsent in Clinical Trials
Catherine Houghton
2020 (Virtual) Annual Meeting
Contributed Session
Potential participants’ views on the factors that impact on their decision to take part in a randomised trial: A qualitative evidence synthesis.
Patricia Vanderwolf
2020 (Virtual) Annual Meeting
Contributed Session
Patient-Focused Research on Metachromatic Leukodystrophy
Richard Hooper
2020 (Virtual) Annual Meeting
Contributed Session
Optimal incomplete designs for stepped wedge trials in continuous time
Anna Heath
2020 (Virtual) Annual Meeting
Contributed Session
Adaptive Seamless Phase II/III Design for the Ketodex trial
Jiyu Kim
2020 (Virtual) Annual Meeting
Contributed Session
Analysis of multicenter clinical trials with very low event rates
ASM Borhan
2020 (Virtual) Annual Meeting
Contributed Session
Analysis and reporting of data from stratified cluster randomized trials – a systematic survey
Emily Hite
2020 (Virtual) Annual Meeting
Contributed Session
An examination of treatment interventions for glioblastoma multiforme and its affect on patient withdrawals/drop outs
Guilherme Lopes
2020 (Virtual) Annual Meeting
Contributed Session
A novel method of reporting adverse effects in cancer clinical trials.
Student finalists presenting their papers and the winner announced live during the webinar!
2020 (Virtual) Annual Meeting
Award Presentation
Thomas C. Chalmers Student Scholarship
Jean-Jacques Muyembe-Tamfum, Lori Dodd, Oliver Tshiani Mbala, and Jamila Adoulhab
2020 (Virtual) Annual Meeting
Trial of the Year Award
Pamoja Tulinde Maisha (PALM ["Together Save Lives"] in the Kiswahili language) trial
SCT President, Officers and Committee Chairs
2020 (Virtual) Annual Meeting
Special Presentation
Annual Business Meeting 2020
Chengwu Yang
2020 (Virtual) Annual Meeting
Award Presentation
Sylvan Green Award
Michael Grayling
2020 (Virtual) Annual Meeting
Contributed Session
Where is the good? The bad and the ugly of single-arm trial reporting
Penny Reynolds
2020 (Virtual) Annual Meeting
Contributed Session
Where have all the trials gone? Academic trialists do not report clinical trial results
James Moore
2020 (Virtual) Annual Meeting
Contributed Session
Wearable Devices: Technology, Time Issues and Statistical Resolutions
Quyen Duong
2020 (Virtual) Annual Meeting
Contributed Session
Understanding Verbosity: Associations between Consent Form Length and Funding Source in Cancer Clinical Trials
Kari Williams
2020 (Virtual) Annual Meeting
Contributed Session
The Impact of Interdisciplinary Relationships on Single IRB Selection in a National Clinical Trial Network
Arsenio Paez
2020 (Virtual) Annual Meeting
Contributed Session
The IDEAL Reporting Guidelines for Reporting the Evaluation of Surgical Innovation
Arsenio Paez
2020 (Virtual) Annual Meeting
Contributed Session
The CONSIDER framework - Guiding intervention fidelity and study design in clinical trials of surgery.
Kathryn Arnold
2020 (Virtual) Annual Meeting
Contributed Session
Successful implementation of a novel trial design in a palliative care population
Xiaoyan Yin
2020 (Virtual) Annual Meeting
Contributed Session
Sequential, Multiple-Assignment, Randomized Trials for COMparing Personalized Antibiotic StrategieS (SMART-COMPASS): Design Considerations for Selecting the Optimal Treatment
Janel Fedler
2020 (Virtual) Annual Meeting
Contributed Session
Sample Size Estimates for Optical Coherence Tomography Outcome Measures Based on Trends Observed in the SPRINT-MS Trial
Kevin Fain
2020 (Virtual) Annual Meeting
Contributed Session
Race and ethnicity reporting for clinical trials in ClinicalTrials.gov and publications.
Muniza Sheikh
2020 (Virtual) Annual Meeting
Contributed Session
National Institute of Neurological Disorders and Stroke (NINDS) Common Data Element (CDE) Recommendations: Project Overview and Recent Updates
Michael Grayling
2020 (Virtual) Annual Meeting
Contributed Session
Multi-arm multi-stage designs with fixed stage-wise sample sizes
Lawrence Ragard
2020 (Virtual) Annual Meeting
Contributed Session
Interdisciplinary collaboration in review of national coverage analysis (NCA) documents to enhance clinical trial site activation and recruitment of participants.
Elias Klemperer
2020 (Virtual) Annual Meeting
Contributed Session
Implementation, recruitment, and retention for an emergency department initiated buprenorphine intervention for opioid use disorder
Elizabeth Wright
2020 (Virtual) Annual Meeting
Contributed Session
Data Sharing Plans in Manuscripts Reporting Results of Randomized Clinical Trials Published in International Committee of Medical Journal Editors Member Journals during 2019
Joseph Rausch
2020 (Virtual) Annual Meeting
Contributed Session
Comparing ANCOVA and Constrained Longitudinal Data Analysis for Examining Moderators in Randomized Clinical Trials
Brian Burke
2020 (Virtual) Annual Meeting
Contributed Session
Closing Out a Long-Term Longitudinal Study: Lessons from the TODAY Study
Chenxiang Li
2020 (Virtual) Annual Meeting
Contributed Session
Generalization of Randomized Trial Results with Latent Motivation – A Propensity Score Approach
Lan Zhang
2020 (Virtual) Annual Meeting
Contributed Session
Buy or Build: Considerations for a robust data management system used in Phase 3 Clinical Studies
James Wise
2020 (Virtual) Annual Meeting
Contributed Session
Building a Comprehensive Clinical Site Performance Portal in Support of Risk-Based Monitoring
Christina Clise
2020 (Virtual) Annual Meeting
Contributed Session
Blurring the Boundaries Between Clinical Trials and Healthcare Ecosystems.
Joel Gagnier
2020 (Virtual) Annual Meeting
Contributed Session
Bias Associated with Patient Reported Outcome Measures in Meta-Analyses
Arsenio Paez
2020 (Virtual) Annual Meeting
Contributed Session
Beyond the RCT: When are randomised trials unnecessary for new therapeutic devices, and what should we do instead?
Carlton Hornung
2020 (Virtual) Annual Meeting
Contributed Session
Assessing the Competency of the Clinical Research Workforce: Formal Education; Role in the Research Enterprise; Research Setting; and Years of Experience.
Tolulope Abidogun
2020 (Virtual) Annual Meeting
Contributed Session
Analysis of Intent to Share Individual Participant Data (IPD) for Clinical Trials Registered on ClinicalTrials.gov
Arsenio Paez
2020 (Virtual) Annual Meeting
Contributed Session
An introduction to ideal
Caroline Kristunas
2020 (Virtual) Annual Meeting
Contributed Session
An evaluation of the use of covariate constrained randomisation for stepped-wedge cluster randomised trial
Gary Gensler
2020 (Virtual) Annual Meeting
Contributed Session
Addressing changes to a closeout data set
Janet Athene Lane
2020 (Virtual) Annual Meeting
Contributed Session
A digital story of strategies for surgical trainees working together to achieve success in conducting surgical clinical trials
Graham Wheeler
2020 (Virtual) Annual Meeting
Educational Session
How to design and run an adaptive clinical trial: new resources and easy-to-use software
James Wagner
2020 (Virtual) Annual Meeting
Educational Session
Improving Quality and Controlling Costs in Clinical Trials Using Responsive Survey Design
Various Speakers
2019 (New Orleans) Annual Meeting
Special Presentation
Special Founders Session
James J. Dignam & Letitia Perdue
2019 (New Orleans) Annual Meeting
Award Presentation
Thomas C. Chalmers Scholarship, Sylvan Green & Poster Awards
Dr. Monica Bertagnolli
2019 (New Orleans) Annual Meeting
Founders Lecture
Building a learning health care system, and learning from every patient
Susan Halabi
2019 (New Orleans) Annual Meeting
Fellows Presentation
Presentation of the Class of 2019 Fellows
Dr. Lynette Keyes-Elstein
2019 (New Orleans) Annual Meeting
Trial of the Year Award
The Scleroderma: Cyclophosphamide or Transplantation (SCOT) trial
Sumithra Mandrekar
2019 (New Orleans) Annual Meeting
Presidential Welcome
Clinical Trials: A Catalyst for Societal Advancement through Innovation
Thomas Fleming
2019 (New Orleans) Annual Meeting
Curtis Meinert Lecture
Striving to achieve and protect the integrity of clinical trials
Li Chen
2019 (New Orleans) Annual Meeting
Session Proposal
Synthesize Read-World Data with Randomized Clinical Trial Data for Efficient Drug Development
Joel Stevans
2019 (New Orleans) Annual Meeting
Contributed Session
Implementation of the Multi-Site Pragmatic Cluster Randomized Controlled Trial: Targeted Interventions to Prevent Chronic Low Back Pain (LBP) in High Risk Patients (TARGET)
Charity Patterson
2019 (New Orleans) Annual Meeting
Contributed Session
MULTIPLE, INNOVATIVE, REDCAP PROJECTS FOR TWO SIMULTANEOUS MULTICENTER TRIALS.
Rebecca Neiberg
2019 (New Orleans) Annual Meeting
Contributed Session
ASSESSING DATA QUALITY OF PARTICIPANT WEIGHTS UPLOADED FROM SMART SCALES: THE STUDY OF NOVEL APPROACHES TO PREVENTION CLINICAL TRIAL – EXTENSION PHASE
Kelley Kidwell
2019 (New Orleans) Annual Meeting
Educational Session
SMART clinical trial design for large and small samples
Shaun Treweek
2019 (New Orleans) Annual Meeting
Contributed Session
Increasing the trial process evidence base without increasing research waste
David Kent
2019 (New Orleans) Annual Meeting
Educational Session
Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects in randomized trials
Juliana Tolles
2019 (New Orleans) Annual Meeting
Session Proposal
Challenges and Best Practices for Data Monitoring Committees (DMCs) Overseeing Adaptive Clinical Trials
Jessica Kasza
2019 (New Orleans) Annual Meeting
Contributed Session
Staircase cluster randomised trial designs
Katie Jentoft
2019 (New Orleans) Annual Meeting
Contributed Session
CONVERTING VALIDATED SCALES INTO CONSOLIDATED ELECTRONIC CASE REPORT FORMS
Shun Fu Lee
2019 (New Orleans) Annual Meeting
Contributed Session
Sample size calculation for cluster randomized crossover trials of multiple periods.
Kerry Avery
2019 (New Orleans) Annual Meeting
Contributed Session
A modular core outcome set for seamless, standardised evaluation and reporting of outcomes throughout the surgical device innovation lifecycle: the COHESIVE study
Kerry Avery
2019 (New Orleans) Annual Meeting
Contributed Session
Developing a hospital-integrated system for electronic patient-reporting, detection and management of symptoms and complications after surgery
Various Speakers
2019 (New Orleans) Annual Meeting
Special Presentation
Annual Business Meeting 2019
Gareth Davies
2019 (New Orleans) Annual Meeting
Contributed Session
Surgeons’ lack of understanding of levels of evidence and trial methodology is a major barrier to randomized trials in surgery
Naveen Pereira
2019 (New Orleans) Annual Meeting
Contributed Session
TAILOR PCI: Transitioning a Genotype Based Randomized Clinical Trial to a Registry Using Digital Solutions
Lisa Bailey
2019 (New Orleans) Annual Meeting
Contributed Session
'Don't Cut it Out': The Importance of Quality Control in Surgical Trials
Kate Harvey
2019 (New Orleans) Annual Meeting
Contributed Session
‘Exploring the feasibility of using mixed methods within an IDEAL 2a/2b study to facilitate the safe, transparent and efficient early-phase evaluation of a novel surgical technique: The Pre-BRA study.’
Kerenza Hood
2019 (New Orleans) Annual Meeting
Contributed Session
‘First do no harm’ – exploring the potential impact of placebo treatments on adverse effects
Shaunagh Browning
2019 (New Orleans) Annual Meeting
Session Proposal
“The Clinical Research Nurse in Clinical Trials: Value Added?” A Panel Discussion on the Nurses' Role on the Clinical Trials Team
Thomas Tollefsen
2019 (New Orleans) Annual Meeting
Contributed Session
“What matters to you?” Preliminary results from a randomized controlled effectiveness trial
Kandi Velarde
2019 (New Orleans) Annual Meeting
Contributed Session
A Bold Collaboration Between the Recruitment Innovation Center (RIC) and the Department of Veterans Affairs (VA) to Develop a Case-Based Framework for Sharing Algorithmic Approaches to Facilitate Clinical Research Planning and Recruitment
Ayoola Ademola
2019 (New Orleans) Annual Meeting
Contributed Session
A Comparison of Frequentist and Bayesian Power Analyses for Non-Inferiority Trials Designs
Gillian Gresham
2019 (New Orleans) Annual Meeting
Contributed Session
A Comparison of Industry and NIH-funded Clinical Trials Registered in ClinicalTrials.gov
Tolu Sajobi
2019 (New Orleans) Annual Meeting
Contributed Session
A Differential Item Functioning Analysis of the DASH Outcome Measure in a Randomized Controlled Trial of Patients with Elbow Fractures
Andrew Chapple
2019 (New Orleans) Annual Meeting
Contributed Session
A Hybrid Phase I-II/III Clinical Trial Design Allowing Dose Re-Optimization in Phase III
Tolulope Sajobi
2019 (New Orleans) Annual Meeting
Contributed Session
A Literature Review of Baseline Covariate Adjustment Methods in Randomized Clinical Trials
Martin Law
2019 (New Orleans) Annual Meeting
Contributed Session
A new class of optimally curtailed trials for phase II oncology trials.
Brittney Bailey
2019 (New Orleans) Annual Meeting
Contributed Session
A new predictive mean matching imputation method for data from cluster randomized trials
RANI JAYSWAL
2019 (New Orleans) Annual Meeting
Contributed Session
A novel method for PFS ratio endpoint in a Phase II genomic-driven clinical trial
Karen Beck
2019 (New Orleans) Annual Meeting
Contributed Session
A Pilot Study to Assess Feasibility and Acceptability of At-Home Self-Collection Sampling for Urine and Saliva
Chaoqun Mei
2019 (New Orleans) Annual Meeting
Contributed Session
A Procedure for Comparison of Matched Pairs by Ranking Method
Hongli Li
2019 (New Orleans) Annual Meeting
Contributed Session
A Programmatic Approach to the Increased Data Monitoring in the Cooperative Group System Required for FDA Registration Trials
Lisa Henn
2019 (New Orleans) Annual Meeting
Contributed Session
A Randomized Controlled Trial with right-skewed dual endpoints in the presence of an unproven but incumbent competing intervention: Rationale and design
Michael Grayling
2019 (New Orleans) Annual Meeting
Contributed Session
A review of software availability for adaptive clinical trials
J Athene Lane
2019 (New Orleans) Annual Meeting
Contributed Session
A systematic literature review of site staff training methods in clinical trials
Thevaa Chandereng
2019 (New Orleans) Annual Meeting
Contributed Session
A Tool for Design and Analysis of Adaptive Bayesian Clinical Trials
Chin-Fu Hsiao
2019 (New Orleans) Annual Meeting
Contributed Session
A two-stage selection designs for basket clinical trials
Zhenning Yu
2019 (New Orleans) Annual Meeting
Contributed Session
A Unified Approach for Frequentist and Bayesian Hypothesis Testing in Two-Arm Clinical Trials with Binary Outcomes
Toshimitsu Hamasaki
2019 (New Orleans) Annual Meeting
Contributed Session
A use of adaptive design in clinical trial for evaluating safety and efficacy of the extracorporeal continuous-flow ventricular assist device in patients with severe heart failure or refractory cardiogenic shock
Julia Robertson
2019 (New Orleans) Annual Meeting
Contributed Session
A Web-Based Approach for Tracking and Management of Sleep Device Mailings for In-Home Sleep Assessments in the WHISPER Study
Katherine Snapinn
2019 (New Orleans) Annual Meeting
Contributed Session
Achieving balance between standardization and customization with the Statisticians’ Report Worksheet
Donna Levy
2019 (New Orleans) Annual Meeting
Contributed Session
Adaptive Designs - Introduction for Non-statisticians - What are they? How do they impact me? What do I need to know?
Yannan Jiang
2019 (New Orleans) Annual Meeting
Contributed Session
All New Zealand Acute Coronary Syndrome - Quality Improvement (ANZACS-QI) Programme: Using Routinely Collected National Patient Database for Clinical Trials
Kevin Fain
2019 (New Orleans) Annual Meeting
Contributed Session
All-cause mortality reporting in ClinicalTrials.gov compared to publications.
Fang-Shu Ou
2019 (New Orleans) Annual Meeting
Contributed Session
Alternative test statistics and their power under non-proportional hazard assumptions
Hayley Belli
2019 (New Orleans) Annual Meeting
Contributed Session
An algorithmic approach for determining individualized stage duration in a Sequential Multiple Assignment Randomized Trial (SMART)
Jacqueline Chen
2019 (New Orleans) Annual Meeting
Contributed Session
Analysis of Drug Labeling for Information Specific to Geriatric Populations
Cindy Cooper
2019 (New Orleans) Annual Meeting
Contributed Session
Anticipated and observed effect sizes in publicly funded randomised controlled trials
Jeffery Oliver
2019 (New Orleans) Annual Meeting
Contributed Session
APPLICATION OF KEY RISK INDICATORS TO IMPROVE DATA QUALITY: A NUTRITION COMPANY’S PERSPECTIVE
Rene Peralta
2019 (New Orleans) Annual Meeting
Contributed Session
Application of the NIST Randomness Beacon to randomized trials.
Jeannette Lee
2019 (New Orleans) Annual Meeting
Contributed Session
Assessing Clinical Trial Self-Perceived Competence Among International Sites Participating in the AIDS Malignancy Consortium
Virginia Shipes
2019 (New Orleans) Annual Meeting
Contributed Session
Assessing the Robustness of Interim Stopping Criteria Methods in Phase III Survival Clinical Trials
Lindsey Cameron-Dermann
2019 (New Orleans) Annual Meeting
Contributed Session
Association between estrogen and prevalent health-related quality of life in postmenopausal women randomized to the MAP.3 chemoprevention trial
Shirley Ge
2019 (New Orleans) Annual Meeting
Contributed Session
Automated Assignment of Congenital Heart Surgery Procedure Types for Accurate Prediction of ICU Length-of-Stay
Wenle Zhao
2019 (New Orleans) Annual Meeting
Contributed Session
Automated Site-Subject Payment Management System for Multi-center Clinical Trials
Amanda MacPherson
2019 (New Orleans) Annual Meeting
Contributed Session
Benefit and burden in trials of novel, disease-modifying interventions in neurodegenerative disease: A systematic review and meta-analysis
Derk Arts
2019 (New Orleans) Annual Meeting
Contributed Session
Benefits of dynamic consent in research - now and tomorrow
Lehana THABANE
2019 (New Orleans) Annual Meeting
Educational Session
Beyond the CONSORT extension for pilot trials: guideline, planning, abstracts and protocols
Joel Gagnier
2019 (New Orleans) Annual Meeting
Contributed Session
Bias Associated With Patient Reported Outcome Measures in Clinical Trials
Lifeng Lin
2019 (New Orleans) Annual Meeting
Contributed Session
Borrowing of strength from indirect evidence in network meta-analyses
Zarah Monfaredi
2019 (New Orleans) Annual Meeting
Contributed Session
Building the infrastructure to support patient engagement in clinical trials within an academic hospital
Yumi Wakabayashi
2019 (New Orleans) Annual Meeting
Contributed Session
Categorization of Medical Information Databases
Pralay Mukhopadhyay
2019 (New Orleans) Annual Meeting
Session Proposal
Challenges in Design, Analysis and Selection of Endpoints in Immuno-Oncology Trials
Susanna Barber
2019 (New Orleans) Annual Meeting
Contributed Session
Challenges to Preventing Pregnancy During Ebola Vaccine Clinical Trials in Liberia
Matthew Parkes
2019 (New Orleans) Annual Meeting
Contributed Session
Change in Pain and Physical Activity in the InRespond Trial: Can Composite Outcomes Improve Responsiveness?
Jianrong Zhang
2019 (New Orleans) Annual Meeting
Contributed Session
Clinical Benefits on Progression-free Survival between Blinded Independent Central Review and Local Assessment in Phase III Randomized Controlled Trials on Solid Tumors: An Analysis of the Results from a Systematic Review
SUSAN Ellenberg
2019 (New Orleans) Annual Meeting
Educational Session
Clinical Trial Data Monitoring Committees and Reporting Statistical Centers: The Basics and Emerging Issues
Cole Wayant
2019 (New Orleans) Annual Meeting
Contributed Session
Clinical trial endpoints in oncology drug advertisements: a potential mechanism for hype?
Mary Redman
2019 (New Orleans) Annual Meeting
Session Proposal
Clinical Trialists Can Help Make Real-World Data Analysis Better
Andrew Pilecki
2019 (New Orleans) Annual Meeting
Contributed Session
Clinical trials and healthcare professionals: An analysis of primary factors driving referral behaviors
Colin Begg
2019 (New Orleans) Annual Meeting
Session Proposal
Clinical Trials: Meet the Editors
Denise Esserman
2019 (New Orleans) Annual Meeting
Session Proposal
Clinical, Practical and Methodological Considerations for Patient Preference Clinical Trials Designs
Larisa Tereshchenko
2019 (New Orleans) Annual Meeting
Session Proposal
Clinician-reported outcomes: can we do better?
Sarah Gaussoin
2019 (New Orleans) Annual Meeting
Contributed Session
COcoa Supplement and Multivitamin Outcomes Study of Cognitive Function (COSMOS-Mind): Design of a Large Randomized Clinical Trial
Matthew` Schipper
2019 (New Orleans) Annual Meeting
Contributed Session
Comparing treatments effect estimates in oncology using randomized clinical trials and observational registries
Adelaide Doussau
2019 (New Orleans) Annual Meeting
Contributed Session
Comparison Between Protocols and Publications for Prognostic and Predictive Cancer Biomarker Studies
Rebecca Lewis
2019 (New Orleans) Annual Meeting
Contributed Session
Considerations in implementing an electronic patient reported outcomes (ePRO) system
Julia Collins
2019 (New Orleans) Annual Meeting
Contributed Session
Considerations in Selection of a Single IRB of Record for Multi-Site Trials
Meaghan Adkisson
2019 (New Orleans) Annual Meeting
Contributed Session
Consistent Data Collection Across Multiple Countries
Peter Kaufmann
2019 (New Orleans) Annual Meeting
Educational Session
Control Groups, Clinically Important Differences and Effect Sizes in Complex Interventions
Jennifer Talton
2019 (New Orleans) Annual Meeting
Contributed Session
Creating Dynamic SAS Reports Across Multiple REDCap Projects
Gillian Lancaster
2019 (New Orleans) Annual Meeting
Contributed Session
Creation of the WHO indicators of Infant and Young Child Development (IYCD) as an outcome measure for assessing pre-primary interventions in low and middle income countries: meta data synthesis and field testing methodology
Diane Hartford
2019 (New Orleans) Annual Meeting
Contributed Session
Crowdsourcing Solutions for RCT Study Start-Up Pain Points
Jack White
2019 (New Orleans) Annual Meeting
Contributed Session
Data Integration in a Multi-site Intervention Through Use of Application Programming Interfaces (APIs)
Andrew Rygiel
2019 (New Orleans) Annual Meeting
Contributed Session
DEFINING EVALUABILITY IN A PHASE II, PROSPECTIVE, NON-RANDOMIZED, PRAGMATIC CANCER CLINICAL TRIAL
Andrea Anderson
2019 (New Orleans) Annual Meeting
Contributed Session
Designing an Adherence Tracking System for an International Trial
Nolan Wages
2019 (New Orleans) Annual Meeting
Educational Session
Designs for modern phase I oncology trials
Julie Croft
2019 (New Orleans) Annual Meeting
Contributed Session
Development of a resource to guide set-up and conduct of international surgical clinical trials
Manqi Cai
2019 (New Orleans) Annual Meeting
Contributed Session
Development of Methods to handle medication non-adherence in Early Phase Dose-Finding
Brett Thombs
2019 (New Orleans) Annual Meeting
Session Proposal
Development of reporting guidelines for randomized controlled trials using cohorts and routinely collected health data
Rhiannon Macefield
2019 (New Orleans) Annual Meeting
Contributed Session
Digital images of surgical wounds taken by patient themselves after leaving hospital: exploring the feasibility of a method for remote and blinded outcome assessment of surgical site infection.
Hayat Ahmed
2019 (New Orleans) Annual Meeting
Session Proposal
Diverse Representation in Clinical Trials
Yuanxi Jia
2019 (New Orleans) Annual Meeting
Contributed Session
Duplicate Patterns and Duplicate Publication Bias among Chinese-sponsored Drug-related Randomized Controlled Trials
Jeremy Wolff
2019 (New Orleans) Annual Meeting
Contributed Session
Electronic Healthcare Record Extraction, Transfer, and Use in Clinical Trials: Lessons Learned
Cory Goldstein
2019 (New Orleans) Annual Meeting
Contributed Session
Emergency research without consent: an ethical analysis of the ketamine versus haloperidol trial
Jianrong Zhang
2019 (New Orleans) Annual Meeting
Contributed Session
Endpoint Surrogacy in Oncological Randomized Controlled Trials with Immunotherapies: A Systematic Review of Meta-analyses
yves rosenberg
2019 (New Orleans) Annual Meeting
Educational Session
Essentials of Clinical Trials
Lori Dodd
2019 (New Orleans) Annual Meeting
Contributed Session
Establishment of Good Clinical Data Management Practices for a Randomized Clinical Trial during an Ebola Outbreak
Victoria Shepherd
2019 (New Orleans) Annual Meeting
Contributed Session
Ethical aspects of surrogate decision-making for clinical trials: a systematic review of empirical research
Madeleine Organ
2019 (New Orleans) Annual Meeting
Contributed Session
Evaluating performance of covariate-constrained randomization (CCR) techniques under misspecification of cluster-level variables
Elizabeth Ryan
2019 (New Orleans) Annual Meeting
Contributed Session
Evaluation of Bayesian adaptive designs for Phase III trials
Anne Welhaven
2019 (New Orleans) Annual Meeting
Contributed Session
Evaluation of Continual Reassessment Method with Lagged Cohort
Khalif Halani
2019 (New Orleans) Annual Meeting
Contributed Session
Evaluation of new methods for valid inference in the presence of selection bias
Elizabeth Louise Turner Turner
2019 (New Orleans) Annual Meeting
Contributed Session
Evaluation of weighting and imputation methods to deal with missing outcomes in cluster randomized trials
Kehao Zhu
2019 (New Orleans) Annual Meeting
Contributed Session
Evolving Practices of Results Reporting in ClinicalTrials.gov
Tracy Wolbach
2019 (New Orleans) Annual Meeting
Contributed Session
Expediting New HIV Therapy to the Market through Collaboration with a Contract Research Organization
Samiha Islam
2019 (New Orleans) Annual Meeting
Contributed Session
Experience in Implementing a Genomic Test Screening Tool as a Patient Identification Aid in a Precision Medicine Oncology Study
Paula Darby Lipman
2019 (New Orleans) Annual Meeting
Contributed Session
EXPLORING CHALLENGES ASSOCIATED WITH EARLY IMPLEMENTATION OF LOW-COST PRAGMATIC TRIALS
Jenny Donovan
2019 (New Orleans) Annual Meeting
Contributed Session
Exploring the translation of the UK QRI (QuinteT Recruitment Intervention) to improve and optimise recruitment to clinical trials in the US
Phyllis Goodman
2019 (New Orleans) Annual Meeting
Contributed Session
Extending Randomized Clinical Trial Results through Database Linkages
KyungMann Kim
2019 (New Orleans) Annual Meeting
Session Proposal
Founders of the Society for Clinical Trials, Inc.
Claire Cochran
2019 (New Orleans) Annual Meeting
Session Proposal
From Grant to GANNT, the challenges of setting up a trial in 2018 – lessons learnt for the international stage
Matthew Parkes
2019 (New Orleans) Annual Meeting
Contributed Session
Futility of the Treatment, Rather than Futility of the Trial, as the Primary Focus of Interim Analyses in Clinical Trials
Bert Arevalo
2019 (New Orleans) Annual Meeting
Contributed Session
GCP Compliance Challenges in Complementary and Alternative Medicine Trials
Geng Li
2019 (New Orleans) Annual Meeting
Contributed Session
Graphical Displays of Patient-Reported Outcomes in Interim Clinical Trial Data Monitoring Committee Reports
Michael Grayling
2019 (New Orleans) Annual Meeting
Contributed Session
Historical and contemporary opinions on the design of phase II oncology trials
Katie Gillies
2019 (New Orleans) Annual Meeting
Session Proposal
How can behavioural science help us design better trials?
Loïc Lebellec
2019 (New Orleans) Annual Meeting
Contributed Session
How to quantify the treatment effect in oncology randomized clinical trials with interval-censored data? Restricted Mean Survival Time Difference versus Hazard Ratio and point estimates: results from a simulation study.
Logan Sirline
2019 (New Orleans) Annual Meeting
Contributed Session
Implementation of an Innovative Lab Kit and Bio-Sample Specimen Tracking Module within a Clinical Trial Management System
Victoria Trapani
2019 (New Orleans) Annual Meeting
Contributed Session
Implementation of Brain Imaging in the Epidemiology of Diabetes Interventions and Complications Study
Chris Cook
2019 (New Orleans) Annual Meeting
Contributed Session
Improving Online Tools for Clinical Trial Design
Marie Kay
2019 (New Orleans) Annual Meeting
Contributed Session
Improving Risk, Safety, and Data Integrity Oversight through Standardized Protocol Deviation Management – A Data Coordinating Center’s Approach
Lawrence Ragard
2019 (New Orleans) Annual Meeting
Contributed Session
IMPROVING TRANSPARENCY IN CLINICAL TRIAL COSTS FOR PARTICIPANTS: NATIONAL CANCER INSTITUTE (NCI) NATIONAL COVERAGE ANALYSIS INITIATIVE SUPPORTED BY THE NCI’S CANCER TRIALS SUPPORT UNIT
Jessica Tran
2019 (New Orleans) Annual Meeting
Contributed Session
Inclusion of Limited English Proficient Individuals in Clinical Research
Marcus Johnson
2019 (New Orleans) Annual Meeting
Contributed Session
Increasing Access to Clinical Research Using an Innovative Mobile Recruitment Approach: The (MoRe) Concept
Nancy Dianis
2019 (New Orleans) Annual Meeting
Contributed Session
Incremental implementation of risk-based monitoring in a resource-constrained environment
Kimberley Goldsmith
2019 (New Orleans) Annual Meeting
Contributed Session
Independent treatment mechanisms of cognitive behavioural treatments for Irritable Bowel Syndrome
Mary Pautler
2019 (New Orleans) Annual Meeting
Contributed Session
Information Sharing through an Interactive Process Map
Lauren Bradley
2019 (New Orleans) Annual Meeting
Contributed Session
Innovative Application of the Jira Software Technology in the Clinical Trial Case Report Form Development Process
Gareth Griffiths
2019 (New Orleans) Annual Meeting
Contributed Session
Innovative digital recruitment and retention tools for more efficient conduct of randomised trials
Chenguang Wang
2019 (New Orleans) Annual Meeting
Session Proposal
Innovative Early Phase Clinical Trial Designs for Cancer Immunotherapy
RANI JAYSWAL
2019 (New Orleans) Annual Meeting
Contributed Session
Interim Monitoring Reports and SAS Macros to Facilitate Reporting and Implementation of Early Phase Clinical Trials
Scott Rushing
2019 (New Orleans) Annual Meeting
Contributed Session
Intervention Adherence Tracking Through Use of an Electronic Participant Engagement Platform
sally Jo zuspan
2019 (New Orleans) Annual Meeting
Session Proposal
Introduction to Quality by Design and Risk Management: Can you get your staff and study teams to bite?
Katie Gillies
2019 (New Orleans) Annual Meeting
Contributed Session
Investigating Clinical Trial Consultations for Discussions of Retention: A Mixed Methods Study
Jessica Overbey
2019 (New Orleans) Annual Meeting
Contributed Session
IS CORRECTING FOR MULTIPLE TESTING NECESSARY IN A PLATFORM TRIAL?
Katie Minichiello
2019 (New Orleans) Annual Meeting
Contributed Session
Is Pre-Screening a Good Option for Master Protocols? The Lung-MAP Story
Andrew Cook
2019 (New Orleans) Annual Meeting
Contributed Session
Is there an inverse relationship between the importance of a research question and the scientific quality of a proposal to answer it? A reassurance for the UK's Public Health Research programme.
Laura Lovato
2019 (New Orleans) Annual Meeting
Educational Session
It Takes a Village: Multi-Disciplinary Approach to Designing Stellar Data Collection Forms
Jemma Hudson
2019 (New Orleans) Annual Meeting
Contributed Session
Joint modelling of quality of life and time-to-event data in an orthopaedic trial
Rick Chappell
2019 (New Orleans) Annual Meeting
Contributed Session
Just-in-Time Consent: Efficiency vs. Ethics
Yuanxi Jia
2019 (New Orleans) Annual Meeting
Contributed Session
Language Bias among Chinese-sponsored Drug-related Randomized Controlled Trials
Jérôme Tanguy
2019 (New Orleans) Annual Meeting
Contributed Session
Learnings from the Adaptive Design journey
Jessica Tran
2019 (New Orleans) Annual Meeting
Contributed Session
Legal and Ethical Considerations for the Inclusion of Limited English Proficient Individuals in Clinical Research: A Literature Review
Cathryn Rankin
2019 (New Orleans) Annual Meeting
Contributed Session
Maintaining a Vigilance for Quality Data
Richard Emsley
2019 (New Orleans) Annual Meeting
Contributed Session
Mediation analysis of complex interventions should reflect the trial design
Eleanor Murray
2019 (New Orleans) Annual Meeting
Educational Session
Methods for Causal Inference from Randomized Trials with Loss to Follow-up or Non-adherence
Laura Morrison
2019 (New Orleans) Annual Meeting
Contributed Session
Minimization as a Randomization Method
Thomas Cook
2019 (New Orleans) Annual Meeting
Contributed Session
Missing Data and Sensitivity Analysis with Implications for Sample Size and Power of Randomized Clinical Trials.
Kerenza Hood
2019 (New Orleans) Annual Meeting
Contributed Session
Moving innovations in neurofeedback in Mental Health into clinical care: developing a framework to enhance translation
Isabelle Weir
2019 (New Orleans) Annual Meeting
Contributed Session
Multivariate meta-analysis model for the difference in restricted mean survival times
Yuanyuan Kong
2019 (New Orleans) Annual Meeting
Contributed Session
Novel Mode and Effectiveness of International Collaborative Clinical Research Training Programs among Chinese Physicians
Gurbakhshash Singh
2019 (New Orleans) Annual Meeting
Contributed Session
On Covariate Adaptive Randomization Methods in Acute Stroke Trials
J Athene Lane
2019 (New Orleans) Annual Meeting
Contributed Session
Optimising recruitment in clinical trials in surgery including strategies for surgical trainees working together to achieve success
Marcus Johnson
2019 (New Orleans) Annual Meeting
Contributed Session
Optimization of a Shared Network Drive to Increase Utilization Efficiency in a Clinical Research Setting
Jennifer Gassman
2019 (New Orleans) Annual Meeting
Contributed Session
Optimizing data capture and management for tolerability outcomes: The BASE Study
Rhiannon Macefield
2019 (New Orleans) Annual Meeting
Contributed Session
Outcome selection and reporting for innovative surgical procedures and devices: a review of current practice in IDEAL/IDEAL-D studies to inform the development of a core outcome set
Patty Davis
2019 (New Orleans) Annual Meeting
Contributed Session
PARTICIPANT-DIRECTED DATA ENTRY VIA iPad IN SINGLE AND MULTI-SITE CLINICAL TRIALS
Sarah Bruschi
2019 (New Orleans) Annual Meeting
Contributed Session
PERFORMING ELIGIBILITY CHECKS FOR COMPLICATED SCENARIOS
Lauren Yesko
2019 (New Orleans) Annual Meeting
Session Proposal
Perspectives on Data Sharing: Preparing, Analyzing, and Conducting Secondary Data Analyses using Publicly Available Clinical Trial Data
yves rosenberg
2019 (New Orleans) Annual Meeting
Session Proposal
Planning and Implementing Key Design Changes in Multicenter Clinical Trials: Lessons Learned from the ISCHEMIA trial experience
David Kerr
2019 (New Orleans) Annual Meeting
Contributed Session
Points of Consideration for the Independence of DMCs and SDACs
Linda Harrison
2019 (New Orleans) Annual Meeting
Contributed Session
Power Calculation for Cross-Sectional Stepped Wedge Cluster Randomized Trials with Variable Cluster Sizes
Jennifer Le-Rademacher
2019 (New Orleans) Annual Meeting
Contributed Session
Practical Considerations for Trial Design using the Mean Survival Time Endpoint
Sarah Tanveer
2019 (New Orleans) Annual Meeting
Contributed Session
Pragmatic Clinical Trials in Headache and Migraine Research: A Scoping Review
Jill Fikowski
2019 (New Orleans) Annual Meeting
Contributed Session
Pre-implementation of a multi-center, Phase IV, Investigator initiated clinical trial: Experiences from the Canadian Research Initiative in Substance Misuse
Eve Jelstrom
2019 (New Orleans) Annual Meeting
Contributed Session
Premature Site Closure during a Multi-site Clinical Trial
Janel Barnes
2019 (New Orleans) Annual Meeting
Session Proposal
Preparing and Submitting Data to Open and Limited-Access Repositories
Wentao Li
2019 (New Orleans) Annual Meeting
Contributed Session
Problematic registration, randomization, and analysis in randomized controlled trials: systematic review of Obstetrics and Gynaecology studies from an African country (2013-2018)
Julia Collins
2019 (New Orleans) Annual Meeting
Contributed Session
Procedural Considerations for the Secure Remote Review of Executed Informed Consent Forms
Marie Kay
2019 (New Orleans) Annual Meeting
Contributed Session
Process Mapping RCT Study Start-Up
Erich Dress
2019 (New Orleans) Annual Meeting
Contributed Session
Prognosticating Outcomes and Nudging Decisions with Electronic Records in the ICU (PONDER-ICU) Trial: Implementation in a learning health system
Fei Yuan
2019 (New Orleans) Annual Meeting
Contributed Session
Projecting post-trial life expectancy and life-gained: Using A Markov Microsimulation Model
Eleanor Murray
2019 (New Orleans) Annual Meeting
Contributed Session
Proposed guidelines for causal inference from pragmatic randomized trials
Lauren Balmert
2019 (New Orleans) Annual Meeting
Contributed Session
Quantile Lost Lifespan: A summary measure for time-to-event data
Dustin Rabideau
2019 (New Orleans) Annual Meeting
Contributed Session
Randomization Inference for a Marginal Treatment Effect in Cluster Randomized Trials
Patricia Morris
2019 (New Orleans) Annual Meeting
Contributed Session
Re-Enrolling Older Adults Eight Years after Original Study Ended: Issues & Solutions
Fatima Alvi
2019 (New Orleans) Annual Meeting
Contributed Session
Reducing Adenoviral Patient Infected Days (RAPID) Study: Success in Masking Subjects and Clinicians to Treatment with Ophthalmic 5% Povidone-Iodine
Eric Hardter
2019 (New Orleans) Annual Meeting
Contributed Session
Regulatory considerations for HHS-sponsored, non-drug human subjects research studies
Bolaji Egbewale
2019 (New Orleans) Annual Meeting
Contributed Session
Relative sample size reduction of three standard statistical methods in the analysis of randomized controlled trials: a simulation study
Melissa Plets
2019 (New Orleans) Annual Meeting
Contributed Session
Rethinking the Traditions of Trial Design: A Rare Cancer Basket Trial as a Motivating Example
Hao Zhu
2019 (New Orleans) Annual Meeting
Session Proposal
Role of Model Informed Drug Development (MIDD) in Drug Development and Regulatory Evaluation
Marion Campbell
2019 (New Orleans) Annual Meeting
Session Proposal
ROLE OF THE EXPERTISE-BASED DESIGN IN TRIALS OF NON-PHARMACOLOGICAL INTERVENTIONS
Spencer Hey
2019 (New Orleans) Annual Meeting
Session Proposal
Safeguarding Public and Patient Trust in Pragmatic Trials Without Written Informed Consent
Nicholas Seewald
2019 (New Orleans) Annual Meeting
Contributed Session
Sample size considerations for comparing dynamic treatment regimens in a sequentially-randomized trial with a continuous longitudinal outcome
Lee Kennedy-Shaffer
2019 (New Orleans) Annual Meeting
Contributed Session
Sample size estimation for stratified individual and cluster randomized trials with binary outcomes
David Zahrieh
2019 (New Orleans) Annual Meeting
Contributed Session
Sample size planning in the design of healthcare delivery intervention trials using the symbolic data framework
Steven julious
2019 (New Orleans) Annual Meeting
Contributed Session
Sample sizes Group Clinical Trials with a Survival Endpoint - It’s Accrual World
Mark Forrest
2019 (New Orleans) Annual Meeting
Contributed Session
Scaling the communication management hurdle: Communications Manager
Julia Collins
2019 (New Orleans) Annual Meeting
Educational Session
Site Selection for Clinical Trials: Tips, Tricks and Process Considerations
John Nichols
2019 (New Orleans) Annual Meeting
Contributed Session
SITE TRACKING SYSTEM FOR ADMINISTRATION AND ORGANIZATION OF CLINICAL SITE-SPECIFIC INFORMATION
Thomas Cook
2019 (New Orleans) Annual Meeting
Contributed Session
Statistical Approaches for Summarizing the Clinical Event Reporting and Adjudication Process.
Jody Ciolino
2019 (New Orleans) Annual Meeting
Educational Session
Statistical Concepts in Clinical Trials for Non-Statisticians
Lu Mao
2019 (New Orleans) Annual Meeting
Contributed Session
Statistical Inference for Complex Time to Event Outcomes under Non-Randomized Cohorts with Application to the INVESTED Trial
Leila Rooshenas
2019 (New Orleans) Annual Meeting
Educational Session
Strategies for optimizing recruitment to randomized clinical trials
Margaret Crawford
2019 (New Orleans) Annual Meeting
Contributed Session
Surmounting Barriers with Targeted Solutions: Launching the Pharmacotherapies for Alcohol and Substance Abuse Consortium
Victoria Shepherd
2019 (New Orleans) Annual Meeting
Contributed Session
Surrogate decision-making for clinical trials: a qualitative exploration of surrogate decision-makers’ experiences
Julie Qidwai
2019 (New Orleans) Annual Meeting
Session Proposal
Switching Boats Mid-Stream: Maintaining Continuity in a Large Clinical Trials Network in the Face of Change
Clement Ma
2019 (New Orleans) Annual Meeting
Contributed Session
TARGET-CRM: a novel adaptive dose-escalation design for targeted therapies with applications in pediatric oncology
Fei Chen
2019 (New Orleans) Annual Meeting
Contributed Session
Testing of Multiple Survival Endpoints in a Group Sequential Design – Control of Familywise Error in CREDENCE
Nicole Edgar
2019 (New Orleans) Annual Meeting
Contributed Session
The BEACON Study: Protocol for a cohort study as part of an evaluation of the effectiveness of smartphone-assisted problem solving therapy in men who present with intentional self-harm to Emergency Departments in Ontario.
Catherine Olivier
2019 (New Orleans) Annual Meeting
Contributed Session
The Challenge of Innovation: Considerations for implementing two-way text messaging for primary outcome data collection in clinical trials
Amy Dwy
2019 (New Orleans) Annual Meeting
Session Proposal
THE COLLABORATION BETWEEN DATA MANAGERS AND MONITORS IN RISK BASED MONITORING IN INTERNATIONAL STUDIES
Charles Opondo
2019 (New Orleans) Annual Meeting
Contributed Session
The Combined Protocol for Acute Malnutrition Study: a cluster randomized non-inferiority trial in Kenya and South Sudan
David DeMets
2019 (New Orleans) Annual Meeting
Session Proposal
The Coronary Drug Project (CDP): Looking Back 50 Years
Adelaide Doussau
2019 (New Orleans) Annual Meeting
Contributed Session
The Ethics of Placebo Sequential Parallel Comparison Design
Greg Ball
2019 (New Orleans) Annual Meeting
Session Proposal
The Global Regulatory Landscape and a Safety Mindset: Medical Judgment and Decision-Making within a Quantitative Framework
Brooke Maracle
2019 (New Orleans) Annual Meeting
Contributed Session
The Influence of Institution Accrual on Patient Survival in Canadian Cancer Clinical Trials
Catherine Meyers
2019 (New Orleans) Annual Meeting
Session Proposal
The Landscape of Embedded Pragmatic Clinical Trials in the US: Focus on Opioid Use and Pain Management
Melanie Bell
2019 (New Orleans) Annual Meeting
Contributed Session
The mixed model for repeated measures for cluster randomized trials (MMRM-CRT): a simulation study investigating bias and type I error with missing continuous data
Karla Hemming
2019 (New Orleans) Annual Meeting
Session Proposal
The multiple-period cluster randomised cross-over design for comparative effectiveness research: statistical and ethical issues
Krista Valladares
2019 (New Orleans) Annual Meeting
Contributed Session
The NeuroNEXT Model: Efficiencies Gained by Deploying an Embedded Research Administrator
Jonathan Kimmelman
2019 (New Orleans) Annual Meeting
Session Proposal
The United States’ Right-To-Try Legislation: Implications for Clinical Trials
ken cheung
2019 (New Orleans) Annual Meeting
Session Proposal
Training the future generation of clinical trial biostatisticians
Claire Cochran
2019 (New Orleans) Annual Meeting
Contributed Session
Traumatic Decisions; Research Recruitment and Randomisation in an Acute Emergency Setting
Alison McDonald
2019 (New Orleans) Annual Meeting
Educational Session
Trial Close 0ut and Archiving
Rebecca Lewis
2019 (New Orleans) Annual Meeting
Contributed Session
Trial salvage: Pragmatic design adaptation in response to recruitment challenges
Edward Mayerson
2019 (New Orleans) Annual Meeting
Contributed Session
Trials, Tribulations, and Triumphs in Coordinating a “Not Otherwise Categorized” Cohort in an Umbrella Trial for Rare Cancers
Rob Basmadjian
2019 (New Orleans) Annual Meeting
Contributed Session
UGT2B17, exemestane metabolism, and their association with physical health-related quality of life in postmenopausal women participating in the Mammary Prevention 3 Trial
Peter Kaufmann
2019 (New Orleans) Annual Meeting
Session Proposal
Unintended consequences of participant engagement in clinical trials involving behavioral interventons.
Giulia Lorenzoni
2019 (New Orleans) Annual Meeting
Contributed Session
Use of wearable devices to monitor physical activity in clinical studies: the CAPABILITY study protocol
Jeffrey McCrindle
2019 (New Orleans) Annual Meeting
Contributed Session
Using AI and Natural Language Generation to Automate Pharmaceutical Clinical Study Reports
Maria Pufulete
2019 (New Orleans) Annual Meeting
Session Proposal
Using observational healthcare data to emulate randomized trials
Shaun Treweek
2019 (New Orleans) Annual Meeting
Educational Session
Using Studies Within a Trial (SWATs) to increase the evidence base for trial process decision-making
David Klements
2019 (New Orleans) Annual Meeting
Contributed Session
Utilizing cloud-based software to increase efficiency and reduce errors and increase efficiency in communication during the conduct of multi-site clinical trials
Kimberley Goldsmith
2019 (New Orleans) Annual Meeting
Session Proposal
What works for whom and why: the future for trials of complex interventions
Mahesh Parmar
2018 (Portland) Annual Meeting
Trial of the Year Award
The Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy (STAMPEDE, NCT00268476)
Fan-fan Yu, Kathleen Reape
2018 (Portland) Annual Meeting
Trial of the Year Award
Efficacy and Safety of Voretigene Neparvovec (AAV2-hRPE65v2) in Patients with RPE65-mediated Inherited Retinal Dystrophy
William C. Cushman
2018 (Portland) Annual Meeting
Founders Lecture
Major VA and NHLBI Clinical Trials That Impacted the Management of Hypertension
Susan Halabi
2018 (Portland) Annual Meeting
Fellows Presentation
Presentation of the Class of 2018 Fellows
James J. Dignam
2018 (Portland) Annual Meeting
Award Presentation
Thomas C. Chalmers Scholarship and Sylvan Green Awards
Steven Goodman
2018 (Portland) Annual Meeting
Curtis Meinert Lecture
Research reproducibility and research reform: lessons from clinical trials
Ted Karrison, PhD
2018 (Portland) Annual Meeting
Presidential Welcome
Welcome - 2017-18 SCT President
Nicola Mills
2018 (Portland) Annual Meeting
Session Proposal
Achieving the impossible? Case studies of successful recruitment to randomised clinical trials considered contentious or impossible
Theodore Lystig
2018 (Portland) Annual Meeting
Session Proposal
Dynamic determination of a power prior parameter – the discount prior approach
Roger J. Lewis
2018 (Portland) Annual Meeting
Session Proposal
Design of an Adaptive Trial of Extra-Corporeal Membrane Oxygenation for Refractory Out-of-hospital Cardiac Arrest (EROCA)
Lehana Thabane
2018 (Portland) Annual Meeting
Session Proposal
In memory of Dave Sackett: Interim data sharing by data safety monitoring boards of trials (Alternative title: Dave Sackett’s last project on interim data sharing by DSMBs of trials)
Catherine Dillon
2018 (Portland) Annual Meeting
Session Proposal
Optimizing investigational drug management to enhance clinical trial operation quality
Jeremy Grimshaw
2018 (Portland) Annual Meeting
Session Proposal
Developing a framework for the ethical design and conduct of pragmatic trials: consultation with the clinical trials community
Greg Ball
2018 (Portland) Annual Meeting
Session Proposal
Dynamic and Interactive Collaboration between Quantitative and Clinical Scientists: Towards a Better Way of Monitoring and Evaluating Safety Data during Clinical Development
Jeremy Grimshaw
2018 (Portland) Annual Meeting
Session Proposal
Introducing the new CONSORT extension for the Stepped-Wedge Cluster Randomised Trial
Professor Jeremy Grimshaw
2018 (Portland) Annual Meeting
Session Proposal
Designing Trials within Implementation Laboratories
Frank Rockhold
2018 (Portland) Annual Meeting
Session Proposal
Open Sharing of Clinical Trial Data
Caitlyn Meinzer
2018 (Portland) Annual Meeting
Session Proposal
Adaptive Timing of Interim Analysis for Primary Efficacy Outcome
Kirsty Loudon
2018 (Portland) Annual Meeting
Contributed Session
“Treatment As Usual” as the comparator in Randomised Controlled Trials: A scoping review of the use of the term over the past five years in six international general medical trial journals.
Katie Gillies
2018 (Portland) Annual Meeting
Contributed Session
‘It’s trying to manage the work’: a qualitative evaluation of recruitment processes within a UK multicentre trial
Sharavi Peeramsetti
2018 (Portland) Annual Meeting
Contributed Session
“Essential data for Data Monitoring Committee (DMC) review – the ideal open and closed session reports”
Barry Main
2018 (Portland) Annual Meeting
Contributed Session
“Forget-me-not” – a protocol for a pilot cluster randomised trial to pilot a core information set intervention for informed consent to invasive procedures including surgery
Eric Hardter
2018 (Portland) Annual Meeting
Contributed Session
A “compound” problem: general strategies and key resources for the utilization of approved, commercially available drugs in a blinded, controlled clinical trial
Boxian Wei
2018 (Portland) Annual Meeting
Contributed Session
A Bayesian Analysis of Small n Sequential Multiple Assignment Randomized Trials (snSMARTs)
Graham Wheeler
2018 (Portland) Annual Meeting
Contributed Session
A BAYESIAN MODEL-FREE APPROACH TO COMBINATION THERAPY PHASE I TRIALS USING CENSORED TIME-TO-TOXICITY DATA
Julia Collins
2018 (Portland) Annual Meeting
Contributed Session
A Comprehensive Customizable Site Readiness Checklist for Efficient Site Activation in a Clinical Trial
Munya Dimairo
2018 (Portland) Annual Meeting
Contributed Session
A consensus-driven reporting guidance for adaptive clinical trials: an Adaptive designs CONSORT Extension (ACE)
Xiaobo Zhong
2018 (Portland) Annual Meeting
Contributed Session
A Gate-keeping Test for Selecting Adaptive Interventions under General SMART Designs
Beata Planeta
2018 (Portland) Annual Meeting
Contributed Session
A New Approach of Modeling Time in Longitudinal Studies Involving Infrequent and Unequally Spaced Measurements
Qinshu Lian
2018 (Portland) Annual Meeting
Contributed Session
A Novel Bayesian Two-stage Design with Dynamic Historical Borrowing Using a Robust Network Meta-analytic-predictive Approach
Brian Egleston
2018 (Portland) Annual Meeting
Contributed Session
A novel randomized Phase 2 trial design that constrains sample size by requiring a sufficient experimental response rate
Haiyan Zheng
2018 (Portland) Annual Meeting
Contributed Session
A robust Bayesian meta-analytic approach for borrowing information across species in phase I clinical trials
Andrew Forbes
2018 (Portland) Annual Meeting
Contributed Session
A simple relationship between power and expected confidence interval width
Katherine Fairhurst
2018 (Portland) Annual Meeting
Contributed Session
A systematic analysis of UK nationally-funded surgical pilot and feasibility study protocols from the last 10 years to inform and optimise future surgical trials.
Erik Doffagne
2018 (Portland) Annual Meeting
Contributed Session
A Targeted Approach to Medical and Safety Reviews
Karla Hemming
2018 (Portland) Annual Meeting
Educational Session
A tutorial on sample size for efficient cluster, cluster cross-over and stepped-wedge randomised trials; including introduction to a practical on-line “app”
Michael Grayling
2018 (Portland) Annual Meeting
Contributed Session
A two-stage version of Fisher’s exact test for multi-arm trials with binary outcome variables
Kelly Miller
2018 (Portland) Annual Meeting
Contributed Session
A UNIQUE COLLABORATION FOR A DATA COORDINATING CENTER
Elizabeth Colantuoni
2018 (Portland) Annual Meeting
Contributed Session
Accounting for baseline prognostic variables and patient drop-out in the analysis of longitudinal outcomes within randomized trials for Alzheimer’s Disease
Kelsey Grantham
2018 (Portland) Annual Meeting
Contributed Session
Accounting for measurement times with a non-uniform correlation structure in sample size determination for multiple-period cluster randomised trials
Keaton Somerville
2018 (Portland) Annual Meeting
Contributed Session
ACHIEVING PROJECTED DATABASE LOCK IN A MULTI-SITE STUDY - A REPORT FROM A NIDA CTN STUDY
Ajar Kochar
2018 (Portland) Annual Meeting
Contributed Session
ADAPTABLE - A Patient-Centered, Pragmatic Randomized Clinical Trial
Laura Flight
2018 (Portland) Annual Meeting
Contributed Session
Adaptive Design Clinical Trials and their Impact on the Health Economic Analysis of Healthcare Technologies - A Qualitative Study
Christopher S. Coffey
2018 (Portland) Annual Meeting
Educational Session
Adaptive Designs - Overview, Hurdles, & Examples
Ben Saville, Ph.D.
2018 (Portland) Annual Meeting
Educational Session
Adaptive Multi-arm Platform Trials
Jonathan Chipman
2018 (Portland) Annual Meeting
Contributed Session
Adaptively Monitoring Clinical Trials with Second-Generation p-values
Jiajun Wen
2018 (Portland) Annual Meeting
Contributed Session
Adverse events in 103 randomized trials on 1st line glaucoma eye drops
Stephanie Wellford
2018 (Portland) Annual Meeting
Contributed Session
All Hands on Deck for Eligibility Checks
Chen Hu
2018 (Portland) Annual Meeting
Session Proposal
Alternatives to Conventional Survival Analysis Metrics for Clinical Trials
Kandi Velarde
2018 (Portland) Annual Meeting
Contributed Session
An Initiative Using Informatics to Facilitate Clinical Research Planning and Recruitment in the VA Health Care System
Jane Candlish
2018 (Portland) Annual Meeting
Contributed Session
Analysis methods for individually randomised trials with partial clustering of outcomes
Heidi Christ-Schmidt
2018 (Portland) Annual Meeting
Contributed Session
Analysis of studies when rescue therapy censors data
Joseph Rausch
2018 (Portland) Annual Meeting
Contributed Session
Analyzing treatment effects and moderators in randomized pre-post clinical trials
Jennifer Le-Rademacher
2018 (Portland) Annual Meeting
Contributed Session
Application of Multi-State Models in Cancer Clinical Trials
Jennifer Goldsack
2018 (Portland) Annual Meeting
Contributed Session
Applying Measurement Science to the Development of Technology-Derived Novel Endpoints for use in Clinical Trials
Daniele Bottigliengo
2018 (Portland) Annual Meeting
Contributed Session
Assessing the external validity of Randomized Clinical Trials: inverse probability weighting approaches on type-2 diabetes data
Hiroko Dodge
2018 (Portland) Annual Meeting
Contributed Session
Behavioral RCT using frequent social interaction to enhance cognitive reserve
Cristina Murray-Krezan
2018 (Portland) Annual Meeting
Contributed Session
BUILDING THE FOUNDATION FOR A STATISTICS AND DATA COORDINATING CENTER WITH LIMITED RESOURCES: THE HERO STUDY, A NATIONWIDE MULTICENTER RANDOMIZED HEPATITIS C TREATMENT TRIAL
Benjamin Carlisle
2018 (Portland) Annual Meeting
Contributed Session
BURDEN AND CLINICAL IMPACT OF COMBINATION THERAPY EXPLORATION FOR NEW ANTICANCER DRUGS
Adina Stoica
2018 (Portland) Annual Meeting
Contributed Session
Calculating Antiretroviral Drug Resistance: An Innovative Open-Source Tool
Rachel Weber
2018 (Portland) Annual Meeting
Contributed Session
CENTRALIZED SOURCE DOCUMENT REVIEW: AN EFFECTIVE TOOL FOR REMOTE REVIEW OF DIGITIZED PAPER SOURCE DOCUMENTS
Wendy Seiferheld
2018 (Portland) Annual Meeting
Contributed Session
Challenges and Lessons Learned from Engaging the ClinicalTrials.gov Protocol Registration and Results System (PRS): An NRG Oncology Experience
Shelly Lensing
2018 (Portland) Annual Meeting
Contributed Session
Challenges and Successes in Recruitment of HIV Infected Persons to a Cancer Prevention Study
Roberta Scherer
2018 (Portland) Annual Meeting
Contributed Session
Challenges in conducting a multi-center trial in US military hospitals
Melissa Plets
2018 (Portland) Annual Meeting
Contributed Session
Challenges in Conducting DART (S1609), a Pioneer Basket Trial for Rare Cancers in a Cooperative Group Setting
Jeannette Lee
2018 (Portland) Annual Meeting
Contributed Session
Challenges of Conducting a Clinical Trial in Youth Correctional Facilities
Andrew Waberski
2018 (Portland) Annual Meeting
Contributed Session
Challenges with Conducting a Trial of Opioid Administration during Anesthesia in Pediatric Patients Undergoing Cardiac Surgery
Kehao Zhu
2018 (Portland) Annual Meeting
Contributed Session
Characteristics and trends of industry sponsored clinical trials with a DMC – insights from ClinicalTrials.gov
Jody Ciolino
2018 (Portland) Annual Meeting
Contributed Session
Choosing a Balancing Criterion for Complex Cluster-Randomized Trials with Continuous Baseline Variables
Rui Wu
2018 (Portland) Annual Meeting
Contributed Session
Classifying No Improvement in Visual Acuity in Children with Amblyopia Using Simulations
Barbara H. Braffett
2018 (Portland) Annual Meeting
Session Proposal
Clinical Studies with Long-term Follow-up: Experiences and Lessons Learned
Jidong Jia
2018 (Portland) Annual Meeting
Session Proposal
Clinical Trials in China – Opportunities and Challenges for International Collaboration
Nisha Grover
2018 (Portland) Annual Meeting
Contributed Session
Collaborative Approach to Conduct User Testing by Non-technical Research Staff
GEORGE KITSARAS
2018 (Portland) Annual Meeting
Contributed Session
Collection of real-time data from participants – interactive text surveys
Walter Ambrosius
2018 (Portland) Annual Meeting
Contributed Session
Combining SAS and LaTeX for DSMB report generation: The ENRGISE Pilot Study
Katherine Guthrie
2018 (Portland) Annual Meeting
Contributed Session
Comparison of mass mailings to Facebook advertising for recruitment of midlife women with bothersome vaginal symptoms
Valerie Durkalski-Mauldin
2018 (Portland) Annual Meeting
Session Proposal
Competing with RVUs: How to successfully balance clinical research and clinical practice for the academic clinical principal investigator
Taylor Swankie
2018 (Portland) Annual Meeting
Contributed Session
Conducting High-Impact, High-Quality Clinical Trials: Site Staff Training as a Component of Quality
Claire Snowdon
2018 (Portland) Annual Meeting
Contributed Session
Conducting Non-commercial Clinical Trials Internationally - Experiences of a UK based Academic Clinical Trials Unit
Andrew Forbes
2018 (Portland) Annual Meeting
Session Proposal
Covariate constrained randomisation for the design of parallel and stepped wedge cluster trials
Ayon Mukherjee
2018 (Portland) Annual Meeting
Contributed Session
Covariate-Adjusted Response-Adaptive Designs for Weibull Distributed Survival Responses
Li Chen
2018 (Portland) Annual Meeting
Session Proposal
Current Development of Adaptive Designs in Clinical Trials
Andrew Forbes
2018 (Portland) Annual Meeting
Contributed Session
Decomposition of the treatment effect estimator in stepped wedge trials: Understanding the horizontal and vertical contributions
Ludovic Trinquart
2018 (Portland) Annual Meeting
Contributed Session
Design Analyses of Randomized Clinical Trials Supporting FDA Cancer Drug Approvals
Amanda Farrin
2018 (Portland) Annual Meeting
Educational Session
Design and Conduct of Efficient, Innovative Pilot & Feasibility Studies for Complex Interventions
Jonathan Cook
2018 (Portland) Annual Meeting
Contributed Session
Design and optimal use of the expertise-based randomised controlled trial design
Keith Pauls
2018 (Portland) Annual Meeting
Contributed Session
Design of an Electronic cIRB Submission Module Integrated Within a Clinical Trial Management System
Isabelle Weir
2018 (Portland) Annual Meeting
Contributed Session
Design of Non-inferiority Randomized Trials Using the Difference in Restricted Mean Survival Times
Lynn Sleeper
2018 (Portland) Annual Meeting
Contributed Session
DESIGN OF THE TEAMMATE TRIAL FOR CHILDREN WITH HEART TRANSPLANT AND DEVELOPMENT OF A NOVEL EFFICIENT ENDPOINT
Lydia Foster
2018 (Portland) Annual Meeting
Contributed Session
Designing a Non-Inferiority Trial: Bayesian versus Frequentist Approach
Jan Jansen
2018 (Portland) Annual Meeting
Contributed Session
Designing efficient trials in major trauma: the case study of REBOA
Jennifer Goldsack
2018 (Portland) Annual Meeting
Contributed Session
Designing study protocols when mobile devices are used for data capture: Recommendations from the Clinical Trials Transformation Initiative
Hakim-Moulay Dehbi
2018 (Portland) Annual Meeting
Contributed Session
Designing two- or three-arm randomized phase 2 selection trials using a margin of practical equivalence
Jamie Jackson
2018 (Portland) Annual Meeting
Contributed Session
Determining Wear Time Validation Algorithms and Cutpoints: Challenges to Using Accelerometry in a Behavioral Randomized Clinical Trial of Adolescents with Congenital Heart Disease
Heather Murray
2018 (Portland) Annual Meeting
Contributed Session
Developing a Remote Statistical Monitoring Plan
Kaleab Abebe
2018 (Portland) Annual Meeting
Contributed Session
Development and implementation of a web-based SAE adjudication system.
Kerry Avery
2018 (Portland) Annual Meeting
Contributed Session
Development of a core outcome set capturing key concepts relevant to safe and efficient evaluation of innovative invasive procedures
Diane Whitham
2018 (Portland) Annual Meeting
Contributed Session
Development of a standardised set of metrics for monitoring site performance in multicentre randomised trials: a mixed methods study
Wendy Lawton
2018 (Portland) Annual Meeting
Contributed Session
Digital Strategies for Making Clinical Trials More Accessible: SWOG’s Website Redesign
Mathew Margolis
2018 (Portland) Annual Meeting
Contributed Session
Do Site Visits Improve Participant Re-Engagement In Longitudinal Clinical Research?
Clement Ma
2018 (Portland) Annual Meeting
Contributed Session
Dual-agent dose escalation methods for pediatric oncology clinical trials
Ashley Hogan
2018 (Portland) Annual Meeting
Contributed Session
DYNAMIC MANUSCRIPT DEVELOPMENT AND TRACKING OF SCIENTIFIC PRODUCTIVITY AND IMPACT
Zhibao Mi
2018 (Portland) Annual Meeting
Contributed Session
Empirical Assessment of Trial Futility in Multicenter Clinical Trials
Carol Knott
2018 (Portland) Annual Meeting
Educational Session
Engaging ‘tricky’ sites: hints and tips
Sangeetha Paramasivan
2018 (Portland) Annual Meeting
Contributed Session
Ethical aspects of clinical trials in India: a systematic review of research in the past two decades
Cory Goldstein
2018 (Portland) Annual Meeting
Contributed Session
Ethical implications for pragmatic trials involving head-to-head comparisons of usual care interventions: an ethical analysis of the MINT trial
Ralph Trane
2018 (Portland) Annual Meeting
Contributed Session
Evaluation of Diabetic Retinopathy Using the ETDRS Severity Scale – Is There A Gold Standard?
Kimberley Goldsmith
2018 (Portland) Annual Meeting
Contributed Session
Evidenced based refinement of treatments – building mechanism evaluation into clinical trials
Nicola Greenlaw
2018 (Portland) Annual Meeting
Contributed Session
Expanding on accepted wisdoms of statistical design and analysis - stratified randomized controlled trials
Katie Gillies
2018 (Portland) Annual Meeting
Contributed Session
Exploring retention in clinical trials: A meta-ethnographic synthesis of studies reporting participant reasons for drop out
Michelle Collinson
2018 (Portland) Annual Meeting
Contributed Session
EXPLORING THE HAWTHORNE EFFECT USING A BALANCED INCOMPLETE BLOCK DESIGN IN THE ASPIRE CLUSTER RANDOMISED CONTROLLED TRIALS
Zhaomian Li
2018 (Portland) Annual Meeting
Contributed Session
Exploring the Impact of the False Discovery Rate to Correct for Multiple Comparisons
Laura Lovato
2018 (Portland) Annual Meeting
Contributed Session
Exploring the potential of clinical trial data sharing: The SPRINT Challenge
Loretta Davies
2018 (Portland) Annual Meeting
Contributed Session
Exploring treatment preference in trials which compare very different interventions: a pre-trial qualitative study
Wynne Norton
2018 (Portland) Annual Meeting
Contributed Session
Extension of the PRECIS-2 tool to assist in planning trials of multi-level interventions
Mallory Hacker
2018 (Portland) Annual Meeting
Contributed Session
Feasibility of a Seven-Day Therapeutic Washout in Early Stage Parkinson’s Disease
Kaitlyn Cook
2018 (Portland) Annual Meeting
Contributed Session
Futility Assessment via the Conditional Power for Cluster-Randomized Trials with Time-to-Event Endpoints
Melissa Schultz
2018 (Portland) Annual Meeting
Contributed Session
Graphical Summaries of Trial Conduct in DMC Reports
Kristen Mason
2018 (Portland) Annual Meeting
Contributed Session
Heat Maps for Database Lock
Heidi Gardner
2018 (Portland) Annual Meeting
Contributed Session
How do trialists go about designing their recruitment strategies? A qualitative interview study with trial stakeholders
Allison Hirst, IDEAL Project Manager & Researcher
2018 (Portland) Annual Meeting
Educational Session
How to use IDEAL (Idea, Development, Exploration, Assessment and Long-term study) to improve surgical innovation research
Asha Khachane
2018 (Portland) Annual Meeting
Contributed Session
IDEAL: Framework and Recommendations for Evaluation of Surgical Innovations
Jody Ciolino
2018 (Portland) Annual Meeting
Contributed Session
Ideas in Randomization Methods for Complex Cluster-Randomized Trials
Garrick Wallstrom
2018 (Portland) Annual Meeting
Contributed Session
Identification of High-efficacy Subgroups in Clinical Trials
Rebecca Simpson
2018 (Portland) Annual Meeting
Contributed Session
Identifying subgroups of children with asthma who are at higher risk of having an unscheduled medical contact in September: A mixed methods study
Thevaa Chandereng
2018 (Portland) Annual Meeting
Contributed Session
Imbalanced
Erik Doffagne
2018 (Portland) Annual Meeting
Contributed Session
Implementing a Scalable Risk-Based Monitoring Strategy
Lauren Yesko
2018 (Portland) Annual Meeting
Contributed Session
Implementing eCRFs in an Emergency Department environment: challenges, enhancements, and lessons learned
Jeremy Wolff
2018 (Portland) Annual Meeting
Contributed Session
Implementing Standardized Assessments in EDC: Benefits and Challenges based on Experience of Integrating the PhenX Toolkit into a Clinical Trials Network
Paul Brocklehurst
2018 (Portland) Annual Meeting
Contributed Session
Improving implementation in Wales through 'The Forum': an update
Sian Cousins
2018 (Portland) Annual Meeting
Contributed Session
Improving RCTs in invasive procedures; a proposed new definition of invasive procedures
Shaun Treweek
2018 (Portland) Annual Meeting
Contributed Session
Improving the evidence base for trial process decision-making: Studies Within A Trial (SWAT) and why we should be coordinating and doing more of them
Dr. Marjorie Jenkins
2018 (Portland) Annual Meeting
Session Proposal
Including Pregnant and Lactating Women in Clinical Trials: Controversies, Challenges and Opportunities
Victoria Trapani
2018 (Portland) Annual Meeting
Contributed Session
Incorporating Aging Measures in a Long-term Multicenter Observational Study: Training and Certification Procedures
Colin Begg
2018 (Portland) Annual Meeting
Session Proposal
Informed Consent and Innovative Trial Designs
Allison Furey
2018 (Portland) Annual Meeting
Contributed Session
Innovative Use of Stacked Area Plots in DMC Reporting
Wenle Zhao
2018 (Portland) Annual Meeting
Contributed Session
Integrated Drug Tracking Module in EDC-CTMS for Operation Quality Assurance in a Large Multicenter Trial
Jaemyung Kim
2018 (Portland) Annual Meeting
Contributed Session
Integrating Neuroimaging Central Repository and Tracking in Clinical Trial Management System
Brian Burke
2018 (Portland) Annual Meeting
Contributed Session
Integrating New Site Coordinators in an Ongoing Long-Term Multi-Site Observational Trial
Michael Frasketi
2018 (Portland) Annual Meeting
Contributed Session
Interactive Reporting and Visualization of Standardized Clinical Data
Toshimitsu Hamasaki
2018 (Portland) Annual Meeting
Contributed Session
Interim evaluation of efficacy or futility in group-sequential trials with two time-to-event outcomes
Brett Hanscom
2018 (Portland) Annual Meeting
Contributed Session
Interim Monitoring using Adaptive, Time-Varying Non-Inferiority Margins
Katie Gillies
2018 (Portland) Annual Meeting
Contributed Session
Interventions to improve retention to clinical trials: a behavioural analysis of effective interventions.
Stephen Nash
2018 (Portland) Annual Meeting
Contributed Session
Introducing a new Stata package for sample size calculation in trials where the outcome is a rate
Jimmy Le
2018 (Portland) Annual Meeting
Contributed Session
Is intraocular pressure, a surrogate outcome, important to patients with glaucoma?
Dixie Ecklund
2018 (Portland) Annual Meeting
Session Proposal
Keeping Your Eye on the Endpoints: Study Closeout Starts from the Beginning
Heather Kopetskie
2018 (Portland) Annual Meeting
Contributed Session
Leveraging Existing Databases for Clinical Trial Data
Sudha Raman
2018 (Portland) Annual Meeting
Contributed Session
Leveraging the Electronic Health Record in a Global Outcomes Trial: Design and Rationale of the HARMONY Outcomes EHR Ancillary
Gail Mallett
2018 (Portland) Annual Meeting
Contributed Session
Maternal Characteristics Associated with Consent and Reasons for Refusal in a Randomized Controlled Trial in Pregnancy
Denise Esserman
2018 (Portland) Annual Meeting
Contributed Session
MEASURING THE IMPACT OF PATIENT PREFERENCE IN CLINICAL TRIALS
Michael Frasketi
2018 (Portland) Annual Meeting
Contributed Session
Medical Image Integration with Clinical Research Systems
Virginia Howard
2018 (Portland) Annual Meeting
Contributed Session
Methods, Successes, and Lessons Learned from Centralized Cognitive Assessment in a Multicenter Clinical Trial of Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis (CREST-2)
Fang-Shu Ou
2018 (Portland) Annual Meeting
Contributed Session
Milestone prediction for time-to-event endpoint monitoring in clinical trials
Brooke Rabe
2018 (Portland) Annual Meeting
Contributed Session
Missing data imputation methods in non-inferiority trials: a simulation study
Elaine Pascoe
2018 (Portland) Annual Meeting
Contributed Session
MISSING DATA IN THE COMPONENTS OF A BINARY COMPOSITE ENDPOINT: IMPLICATIONS FOR THE COMPOSITE
Virginia Nido
2018 (Portland) Annual Meeting
Contributed Session
MOBILE TECHNOLOGY AND CLINICAL TRIALS: PATIENT PERSPECTIVES AND OPPORTUNITIES TO REDUCE THE BURDEN OF PARTICIPATION
Danni Liu
2018 (Portland) Annual Meeting
Contributed Session
Modeling Correlated Ocular Outcomes when Both Eyes from Some but Not All Participants are Enrolled
Brian Burke
2018 (Portland) Annual Meeting
Contributed Session
Monitoring and Adjudication of Comorbidities in a Multi-Center Observational Study of Youth with Type 2 Diabetes
Jennifer Gassman
2018 (Portland) Annual Meeting
Contributed Session
Monitoring and Reporting blood pressure data quality and data completeness and blood pressure treatment arm separation for the Blood Pressure in Dialysis (BID) Pilot Study
Jason McCoy
2018 (Portland) Annual Meeting
Contributed Session
Monitoring Interactive Response Technology Vendor Implemented Randomization and Dosing Systems
Anna Bowers
2018 (Portland) Annual Meeting
Contributed Session
MONITORING OF MEDICAL EVENTS AND ADJUDICATION THROUGH CUSTOMIZABLE DIGITAL WORKFLOWS IN THE DIABETES PREVENTION PROGRAM OUTCOMES STUDY (DPPOS)
Haley Hedlin
2018 (Portland) Annual Meeting
Contributed Session
Monitoring rare events during an ongoing clinical trial
Stacey Slone
2018 (Portland) Annual Meeting
Contributed Session
My Data, Your Data, Where’s the Data?
Jonathan Cook
2018 (Portland) Annual Meeting
Contributed Session
New guidance on specifying the target difference (“effect size”) for a RCT
Claire Boyle
2018 (Portland) Annual Meeting
Contributed Session
NHANES as a Comparator Cohort
Ying Yuan
2018 (Portland) Annual Meeting
Educational Session
Novel Adaptive Designs for Phase I and II Clinical Trials
Paola Berchialla
2018 (Portland) Annual Meeting
Contributed Session
Objective inference to adjust for baseline covariates in the analysis of randomized controlled trials for increasing efficiency
Daniel Benjamin
2018 (Portland) Annual Meeting
Contributed Session
On the Accuracy of Oncology Experts’ Predictions about Safety in Randomized Cancer Trials
Pamela Tenaerts
2018 (Portland) Annual Meeting
Contributed Session
One decade of impact. One vision ahead. Optimizing the power of public-private partnership: Lessons learned from the Clinical Trials Transformation Initiative
Steven Edland
2018 (Portland) Annual Meeting
Contributed Session
Optimal Composite Endpoints for Clinical Trials of Chronic Progressive Disease
J Athene Lane
2018 (Portland) Annual Meeting
Contributed Session
Optimising recruitment in clinical trials in surgery: how do surgical trainees working together achieve success?
Sian Cousins
2018 (Portland) Annual Meeting
Contributed Session
Optimising the design of placebo-controlled RCTs of invasive procedures: An analysis of published RCTs
Jay Siegel
2018 (Portland) Annual Meeting
Contributed Session
Optimizing Phase II Clinical Trials
Jennifer Goldsack
2018 (Portland) Annual Meeting
Contributed Session
Optimizing the selection of mobile devices for data capture in clinical trials: Recommendations from the Clinical Trials Transformation Initiative
Alice Biggane
2018 (Portland) Annual Meeting
Contributed Session
Participant Input in Core Outcome Set Development: Qualitative Study
Caroline Hurley
2018 (Portland) Annual Meeting
Contributed Session
Perceived barriers and facilitators to Risk Based Monitoring in academic- led clinical trials – a mixed methods study
Graham Wheeler
2018 (Portland) Annual Meeting
Contributed Session
PHASE I TRIALS OF IMMUNOTHERAPIES AND MOLECULARLY TARGETED AGENTS: WHAT DESIGNS ARE USED, AND HOW WELL ARE THEY REPORTED?
Jose Jimenez
2018 (Portland) Annual Meeting
Contributed Session
Phase I/II Bayesian adaptive design with drug combinations and time-to-event data
Jonathan Cook
2018 (Portland) Annual Meeting
Session Proposal
Placebo and sham controlled trials in surgery and in other invasive procedures: lessons, ethics and design issues
RANI JAYSWAL
2018 (Portland) Annual Meeting
Contributed Session
Practical Methods for Utilization of Biomarkers to Assess Cancer Prognosis
Scott Evans
2018 (Portland) Annual Meeting
Session Proposal
Pragmatic Benefit:risk Assessment in Clinical Trials: A New Paradigm Using Pairwise Comparison of Patients
Paula Darby Lipman
2018 (Portland) Annual Meeting
Contributed Session
Pragmatic trial management: Exploring evidence for trial planning milestones
Kirsty Loudon
2018 (Portland) Annual Meeting
Educational Session
Precisely how can this tool help investigators design trials to achieve practical answers to “real world” questions?
Sonia Davis Thomas
2018 (Portland) Annual Meeting
Contributed Session
Predictive modeling of outcomes in a clinical trial with missing baseline data
Heidi Gardner
2018 (Portland) Annual Meeting
Contributed Session
Presenting user-tested evidence based tools to support development of trial recruitment strategies
on behalf of Bluebelle Study Group
2018 (Portland) Annual Meeting
Contributed Session
PSYCHOMETRIC AND INITIAL CLINICAL VALIDATION OF THE BLUEBELLE WOUND HEALING QUESTIONNAIRE (WHQ): A NEW OUTCOME MEASURE FOR POST-DISCHARGE ASSESSMENT OF WOUNDS FOR SURGICAL SITE INFECTION
Elizabeth Wright
2018 (Portland) Annual Meeting
Contributed Session
Randomized Clinical Trial Abstracts Submitted to Major Medical Meetings: Do They Include Trial Registration Numbers and Conform to Consort Guidelines?
Mackenzie Dome
2018 (Portland) Annual Meeting
Contributed Session
Reach Out: Randomized Clinical Trial of Emergency Department-Initiated Hypertension Behavioral Intervention Connecting Multiple Health Systems
Yong Zang
2018 (Portland) Annual Meeting
Session Proposal
Recent Developments in Umbrella, Basket and Platform Trial Designs
Karen Bracken
2018 (Portland) Annual Meeting
Contributed Session
Recruiting men aged 50-74 years to a large diabetes prevention trial: the effectiveness of traditional vs online promotional strategies
Jamie Soames
2018 (Portland) Annual Meeting
Contributed Session
Reducing unnecessary antibiotic prescribing in primary care: a point-of-care electronic intervention using electronic healthcare records (REDUCE Trial)
Shing Lee
2018 (Portland) Annual Meeting
Session Proposal
Reproducible Clinical Trials
Melanie Bell
2018 (Portland) Annual Meeting
Contributed Session
Responder analysis with missing data: comparison of two imputation techniques in the context of randomized controlled trials
Clare Relton
2018 (Portland) Annual Meeting
Contributed Session
RETHINKING THE ARCHITECTURE OF PRAGMATIC TRIALS
Amber Randall
2018 (Portland) Annual Meeting
Contributed Session
Risk-based Validation in Clinical Trial Reporting: Focus on What Matters Most
Simon Day (tentative)
2018 (Portland) Annual Meeting
Session Proposal
Role of Data Monitoring Committees in Complicated Trials
David Collister
2018 (Portland) Annual Meeting
Contributed Session
Run-in periods in randomized controlled trials of chronic diseases: a meta-epidemiologic study
Wayne Feng
2018 (Portland) Annual Meeting
Contributed Session
Safety and tolerability of transcranial direct current stimulation to stroke patients - A phase I current escalation study
Wei Wang
2018 (Portland) Annual Meeting
Contributed Session
Safety Assessment Committee Joins with Data Monitoring Committee - Safety Is the New Efficacy
Maria Ciarleglio
2018 (Portland) Annual Meeting
Contributed Session
Sample Size Estimation Using a Hybrid Classical and Bayesian Procedure
DANILA AZZOLINA
2018 (Portland) Annual Meeting
Contributed Session
Sample size issues for non-inferiority clinical trials with multiple primary endpoints
Jennifer Goldsack
2018 (Portland) Annual Meeting
Contributed Session
Selecting Technology Derived Novel Endpoints for Development and Inclusion in Clinical Trials
Ying Liu
2018 (Portland) Annual Meeting
Contributed Session
SEQUENTIAL MULTIPLE ASSIGNMENT RANDOMIZED TRIALS FOR COMPARING PERSONALIZED ANTIMICROBIAL STRATEGIES (SMART COMPASS)
Sarah Finlayson
2018 (Portland) Annual Meeting
Contributed Session
Should we plan for the unplanned? Managing undesirable but unavoidable protocol amendments in clinical trials.
Kaitlyn Antonelli
2018 (Portland) Annual Meeting
Contributed Session
Site Activation Processes Predictive of Enrollment Success in a Pragmatic Precision Medicine Study
Karen Innes
2018 (Portland) Annual Meeting
Contributed Session
Site Initiation Training – What can be learned from evaluating this process from multicentre trials?
Hyunsook Chin
2018 (Portland) Annual Meeting
Contributed Session
Site Investigator vs. Sponsor SAE Causality: Are they different?
Shaun Treweek
2018 (Portland) Annual Meeting
Contributed Session
Sixty-eight studies and (nearly) nothin’ on: the poor state of the recruitment intervention methodology literature and what to do about it
Marta Bofill Roig
2018 (Portland) Annual Meeting
Contributed Session
Sizing clinical trials with composite binary endpoints
Riaz Qureshi
2018 (Portland) Annual Meeting
Contributed Session
Standardized Reporting of Randomized Clinical Trials for Systematic Reviews: Systematic Review Data Repository
Rebecca Paulus
2018 (Portland) Annual Meeting
Educational Session
Statistical Graphs in SAS Using Graphics Template Language (GTL)
Abigail Baldridge
2018 (Portland) Annual Meeting
Contributed Session
StatTag for Connecting R, SAS, and Stata to Word: A Practical Approach to Reproducibility
Abigail Baldridge
2018 (Portland) Annual Meeting
Educational Session
StatTag for Connecting R, SAS, and Stata to Word: A Practical Approach to Reproducibility
Heidi Gardner
2018 (Portland) Annual Meeting
Contributed Session
Strategies to improve participant recruitment to randomised controlled trials: A systematic review of non-randomised evaluations
Adel Gomaa Ibrahim El Feky
2018 (Portland) Annual Meeting
Contributed Session
Strategies to improve participant retention to randomized controlled trials: what do non-randomized evaluations of retention strategies have to tell us?
Tsedenia Bezabeh
2018 (Portland) Annual Meeting
Contributed Session
STREAMLINING THE PROTOCOL OVERSIGHT PROGRAM FOR MAXIMUM EFFICIENCY IN THE DIABETES PREVENTION PROGRAM OUTCOMES STUDY (DPPOS)
Kimberley Goldsmith
2018 (Portland) Annual Meeting
Educational Session
Studying Treatment Mechanisms – A Whistle Stop Tour of Simple Mediation Analysis
Eileen Stock
2018 (Portland) Annual Meeting
Contributed Session
Surveillance of Serious Adverse Events in a Multisite Clinical Trial utilizing VA Healthcare Administrative Data
Anna Moseley
2018 (Portland) Annual Meeting
Contributed Session
SURVIVAL BY HISPANIC ETHNICITY AMONG CANCER PATIENTS PARTICIPATING IN SWOG CLINICAL TRIALS
Jade Fiotto
2018 (Portland) Annual Meeting
Contributed Session
Telephonic Informed Consent for Point of Care (POC) Clinical Trials
Letitia Perdue
2018 (Portland) Annual Meeting
Contributed Session
The Central IRB Experience in a Minimal Risk Observational Study
William Wood
2018 (Portland) Annual Meeting
Contributed Session
THE CHALLENGES AND OPPORTUNITIES OF MOBILE TECHNOLOGY: A QUALITATIVE EXAMINATION OF INVESTIGATORS’ EXPERIENCES AND RECOMMENDATIONS
Jonathan Gibb
2018 (Portland) Annual Meeting
Contributed Session
The Data Extract Verify File – an open source and cross platform XML file to verify data extracts
Mary Putt
2018 (Portland) Annual Meeting
Contributed Session
The Habit Formation Trial to Evaluate Behavioral Economic Interventions to Reduce the Risk of Cardiovascular Disease: Lessons Learned
Tianchen Qian
2018 (Portland) Annual Meeting
Session Proposal
The Micro-Randomized Trial Design for developing adaptive mobile health interventions
Mitra Lewis
2018 (Portland) Annual Meeting
Contributed Session
The National Drug Abuse Treatment Clinical Trials Network (NDAT CTN) Strategic Planning Group on Retention: Lessons Learned and Best Practices
Nicholas Seedorff
2018 (Portland) Annual Meeting
Contributed Session
The National Institute of Neurology Disorders and Stroke Clinical Trials Methodology Course: Outcomes of Trainees after 3 Years
Yuko Palesch
2018 (Portland) Annual Meeting
Session Proposal
The Role of Central IRB vs DSMB in the Decision Making Process for Premature Termination or Enrollment Suspension of a Multicenter Trial
Jessica Kasza
2018 (Portland) Annual Meeting
Contributed Session
The standard error of the treatment effect in stepped wedge trials when the within-cluster correlation structure is misspecified
Andrea Viecelli
2018 (Portland) Annual Meeting
Contributed Session
The Standardized Outcomes in Nephrology – Hemodialysis (SONG-HD) Initiative: establishing a core outcome set for trials in patients on hemodialysis
David Kerr
2018 (Portland) Annual Meeting
Contributed Session
The Ugly Truths of Today’s DMCs – and What the SDAC Can Do to Help
Nicholas Fergusson
2018 (Portland) Annual Meeting
Contributed Session
The win ratio approach in kidney transplant trials
Ales Kotalik
2018 (Portland) Annual Meeting
Contributed Session
The win ratio approach to the analysis of a composite outcome in the Multiple Risk Factor Intervention Trial
Brian Traver
2018 (Portland) Annual Meeting
Contributed Session
Time-Course Graphics for Individual Subjects In DMC Reports
David Kerr
2018 (Portland) Annual Meeting
Educational Session
Training the Next Generation of DMC Members and the Teams that Support Them
Eve Jelstrom
2018 (Portland) Annual Meeting
Contributed Session
Translating Assessments in Clinical Trials Conducted in the US
Claire Cochran
2018 (Portland) Annual Meeting
Contributed Session
Traumatic Decisions; Research Recruitment and Randomisation in an Acute Emergency Setting
Roberta Scherer
2018 (Portland) Annual Meeting
Contributed Session
Treatment adherence in the Tinnitus Retraining Therapy Trial
Lucy Beasant
2018 (Portland) Annual Meeting
Contributed Session
Treatment preference in pediatric randomised clinical trials: systematic review and qualitative synthesis
Navneet Hakhu
2018 (Portland) Annual Meeting
Contributed Session
TWO FACTORS IMPACTING FORMULATION OF DATA MONITORING COMMITTEE RECOMMENDATIONS FOR ADAPTIVE DESIGN CLINICAL TRIALS
Michael J. Grayling
2018 (Portland) Annual Meeting
Educational Session
Understanding adaptive designs through single-arm trials
Katherine Fairhurst
2018 (Portland) Annual Meeting
Contributed Session
Understanding progression from an internal pilot to a main trial: exploring views and perceptions of key stakeholders.
J athene Lane
2018 (Portland) Annual Meeting
Contributed Session
Understanding strategies and practices that influence retention in clinical trials through an interview study of trial staff in five multi-centre trials
Lesley Curtis
2018 (Portland) Annual Meeting
Contributed Session
Understanding the Clinical Trial Enterprise’s Newest Trend: Incorporating Real-World Evidence into Randomized Clinical Trials
Chin-Fu Hsiao
2018 (Portland) Annual Meeting
Contributed Session
Use of A Bayesian Approach to Incorporate Toxicity Consideration Into The Two Stage Design of Phase II Clinical Trials
Brian Perry
2018 (Portland) Annual Meeting
Contributed Session
Use of Qualitative Data Analysis Software to Facilitate a Systematic Literature Review
Patricia Morris
2018 (Portland) Annual Meeting
Contributed Session
Using a Professional Tracing Service to Locate Participants 6 Years After Study Close-out
Jennifer Goldsack
2018 (Portland) Annual Meeting
Contributed Session
Using a single, central IRB for a nationwide pragmatic clinical trial using claims data
Kathryn Jackson
2018 (Portland) Annual Meeting
Contributed Session
Using Composite Surrogate Baseline Variables in a Modified Covariate-Constrained Randomization Algorithm
Pablo Serrano
2018 (Portland) Annual Meeting
Contributed Session
USING ELECTRONIC DATABASES TO INCREASE ACCRUAL TO GASTROINTESTINAL CANCER CLINICAL TRIALS
Lin Wang
2018 (Portland) Annual Meeting
Contributed Session
Using FDA website and ClinicalTrials.gov to identify trials for network meta-analysis: A case study on first-line medications for glaucoma
Ian Wadsworth
2018 (Portland) Annual Meeting
Contributed Session
Using model-based approaches for determining optimal dosing rules in children
Ron Marks
2018 (Portland) Annual Meeting
Contributed Session
Using Phase 2 Clinical Trial Design to Enhance the Phase 3 Process
Kellee Miller
2018 (Portland) Annual Meeting
Contributed Session
Using Qualitative Data to Develop and Refine Interventions
Shaun Treweek
2018 (Portland) Annual Meeting
Educational Session
Using Studies Within a Trial (SWATs) to increase the evidence base for trial recruitment and retention decision-making
Marcus Johnson
2018 (Portland) Annual Meeting
Contributed Session
Utilization of a Paired Comparison Analysis Framework to Inform and Prioritize Decision-Making in a Highly Matrixed Clinical Research Program
Dagmar Salazar
2018 (Portland) Annual Meeting
Contributed Session
Utilizing a Robust and Comprehensive Locator Form as a Retention Tool in Clinical Trials
Daniel Goldenholz
2018 (Portland) Annual Meeting
Contributed Session
Variability adjusted time to event (VATE) method for analysis of randomized clinical trials in epilepsy and other episodic diseases
Shun Fu Lee
2018 (Portland) Annual Meeting
Contributed Session
Variations in Design of the Stepped Wedge Cluster Randomized Trial: illustration of statistical concepts using the Patient-Centered Care Transitions in Heart Failure (PACT-HF) Trial
Alan Stevenson
2018 (Portland) Annual Meeting
Contributed Session
Video Adjudication in Clinical Trials: Enabling Distribution of Expertise and Accurate Scoring
Catherine Meyers
2018 (Portland) Annual Meeting
Session Proposal
What Are We Learning from Pragmatic Clinical Trials? Design, Implementation and Analytic Strategies
Isoken Odia
2018 (Portland) Annual Meeting
Contributed Session
WHAT IS THE EFFECT OF TREATMENT CROSSOVER ON AN INTENTION TO TREAT ANALYSIS IN A NON-INFERIORITY TRIAL?
merrick.zwarenstein@ices.on.ca
2018 (Portland) Annual Meeting
Session Proposal
When pragmatism and reality collide: use of the PRECIS 1 and 2 tools in PCORI funded trials
Kristen Wroblewski
2018 (Portland) Annual Meeting
Contributed Session
Why Not Buckley-James? A Simulation Study
J. Michael Gaziano
2017 (Liverpool) Annual Meeting
Founders Lecture
The Million Veteran Program: A Modern Mega-Cohort within a Healthcare system Using Big Health Data to Improve Health Care
Jerry Wolinsky
2017 (Liverpool) Annual Meeting
Trial of the Year Award
ORATORIO
James J. Dignam
2017 (Liverpool) Annual Meeting
Award Presentation
Thomas C. Chalmers Scholarship and Sylvan Green Awards
Susan S. Ellenberg
2017 (Liverpool) Annual Meeting
Curtis Meinert Lecture
Clinical Trials in the Twenty-First Century: Ongoing Challenges and Emerging Issues
Will Meurer & Jon Nichols
2017 (Liverpool) Annual Meeting
Special Presentation
Opening Remarks, Program Scientific Committee Co-Chairs
Susan Halabi
2017 (Liverpool) Annual Meeting
Fellows Presentation
Presentation of the Class of 2017 Fellows
Siobhan Bourke
2017 (Liverpool) Annual Meeting
Contributed Session
Rituximab for the treatment of neuromyelitis optica: an application of individual patient data meta-analysis in a rare disease.
Clare Clement
2017 (Liverpool) Annual Meeting
Contributed Session
"To have and to hold, from this day forward": Understanding current practice regarding retention of trial particpants
Clare Clement
2017 (Liverpool) Annual Meeting
Contributed Session
‘Enquiry into how Qualitative Methods Influence Trials and their Yields’ (EQUITY): Exploring registered trials that include a reported qualitative component
Loretta Davies
2017 (Liverpool) Annual Meeting
Contributed Session
“I struggle with equipoise”: a qualitative study exploring clinicians’ views of a randomised controlled trial (ACL SNNAP) prior to trial conduct
Andrew Embleton
2017 (Liverpool) Annual Meeting
Contributed Session
“If a tree falls in a forest…”: Abstract view statistics as a measure of research impact
Alex Nicolson
2017 (Liverpool) Annual Meeting
Contributed Session
“More than the Emperor’s new clothes”: Enhancing meaningful Patient and Public Involvement in Trial Oversight Committees through qualitative research with eight clinical trials facing challenges
Mary Rauchenberger
2017 (Liverpool) Annual Meeting
Contributed Session
“Will you walk a little faster?” - Joining the database development dance
Laura Pankhurst
2017 (Liverpool) Annual Meeting
Contributed Session
40 is the magic number
Alexina Mason
2017 (Liverpool) Annual Meeting
Contributed Session
A Bayesian framework to address missing not at random data in longitudinal studies with multiple types of missingness
Moreno Ursino
2017 (Liverpool) Annual Meeting
Contributed Session
A Bayesian weighted quasi-likelihood design for Phase I/II clinical trial with repeated dose administration in preterm newborns.
Alba Realpe
2017 (Liverpool) Annual Meeting
Contributed Session
A case study method to support and promote recruitment at a multi-centre RCT comparing surgical versus non-surgical treatments
Joy Esterlitz
2017 (Liverpool) Annual Meeting
Contributed Session
A Common Data Language for Clinical Research Studies: Five (5) New Disease Recommendations from the National Institute of Neurological Disorders and Stroke, National Institutes of Health Common Data Elements Project
Brennan Kahan
2017 (Liverpool) Annual Meeting
Contributed Session
A comparison of adjudication approaches for clinical trials
Lesley-Anne Carter
2017 (Liverpool) Annual Meeting
Contributed Session
A comparison of baseline as response and missing indicator methods for missing baseline data in a mixed design cluster randomised control trial
Jemma Hudson
2017 (Liverpool) Annual Meeting
Contributed Session
A comparison of methods to handle missing data in the analysis of an area under the curve outcome
Ines Rombach
2017 (Liverpool) Annual Meeting
Contributed Session
A comparison of statistical approaches for analysing missing longitudinal patient reported outcome data in randomised controlled trials
Peter Godolphin
2017 (Liverpool) Annual Meeting
Contributed Session
A comparison of stroke diagnosis at trial entry by local clinicians versus independent adjudicators: secondary analysis and simulation
Marcus Johnson
2017 (Liverpool) Annual Meeting
Contributed Session
A Cross-Cutting Approach to Clinical Trial Success: The US Department of Veterans Affairs’ Network of Dedicated Enrollment Sites (NODES) Model
Suzanne Freeman
2017 (Liverpool) Annual Meeting
Contributed Session
A framework for identifying treatment-covariate interactions in individual participant data network meta-analysis
Gordon Fernie
2017 (Liverpool) Annual Meeting
Contributed Session
A good use of time and money? A study of how trial data collection effort is distributed across different categories of data.
Toby Prevost
2017 (Liverpool) Annual Meeting
Contributed Session
A journey from statistical consultation to funded adaptive trial
Iryna Schlackow
2017 (Liverpool) Annual Meeting
Contributed Session
A lifetime disease model based on an RCT: development, validation and applications
Pankaj Mistry
2017 (Liverpool) Annual Meeting
Contributed Session
A literature review of the use of Adaptive Design methods in Oncology trials.
Derk Arts
2017 (Liverpool) Annual Meeting
Contributed Session
A look at the future of data standardization and sharing in clinical research.
Graham Wheeler
2017 (Liverpool) Annual Meeting
Contributed Session
A model-free Bayesian adaptive design for combination therapy dose-finding trials with censored time-to-toxicity data
Claire Dyer
2017 (Liverpool) Annual Meeting
Contributed Session
A Multi-Centred Study Validating a Bleeding Assessment Tool (BAT) Developed by the Biomedical Excellence for Safer Transfusion (BEST) Collaborative For Use in Adult Patients with Haematological Malignancy
Matteo Quartagno
2017 (Liverpool) Annual Meeting
Contributed Session
A new design for trials for finding optimal treatment duration
Emma Wang
2017 (Liverpool) Annual Meeting
Contributed Session
A novel approach to analysis of clinical trials for rare cancers assuming symmetry
Hannah Buckley
2017 (Liverpool) Annual Meeting
Contributed Session
A Phase II randomised controlled trial with biomarkers in soft tissue sarcoma: application of a biomarker stratified design
Elizabeth Randell
2017 (Liverpool) Annual Meeting
Contributed Session
A pilot randomised controlled trial of community led anti-psychotic drug reduction for adults with learning disabilities: ANDREA-LD
Meng Liu
2017 (Liverpool) Annual Meeting
Contributed Session
A predictive probability interim design for phase II clinical trials with continuous endpoints
Toshimitsu Hamasaki
2017 (Liverpool) Annual Meeting
Contributed Session
A Program for Training the Next Generation of Biostatisticians in Japan: Developing On-the-Job Training at NCVC
Caitlin O'Hara
2017 (Liverpool) Annual Meeting
Contributed Session
A qualitative feasibility study to inform fluids in shock (FiSh) - a pilot randomised controlled trial of fluid bolus therapy in septic shock
Caroline Rick
2017 (Liverpool) Annual Meeting
Contributed Session
A reflection on the management of a trial of speech and language therapy.
James Howlett
2017 (Liverpool) Annual Meeting
Contributed Session
A Response-Adaptive Trial to Determine the Optimal IL-2 Dose-Frequency to Achieve Multiple Target Increases on Regulatory T Cells in Type 1 Diabetes: DILfrequency study
Isabelle Smith
2017 (Liverpool) Annual Meeting
Contributed Session
A review of design and analysis methods for pressure ulcer research
Daniel Greenwood
2017 (Liverpool) Annual Meeting
Contributed Session
A review of dose escalation methods in first-in-human small molecule oncology clinical trials
Dewen Yang
2017 (Liverpool) Annual Meeting
Contributed Session
A Review of the Essentials and Pitfalls of the Lugano Classification in Malignant Lymphoma Trials
Jelena Savovic
2017 (Liverpool) Annual Meeting
Contributed Session
A revised tool for assessing risk of bias in randomized trials (RoB 2.0)
Andrew Forbes
2017 (Liverpool) Annual Meeting
Contributed Session
A simple relationship between power and expected confidence interval width
Diane Whitham
2017 (Liverpool) Annual Meeting
Contributed Session
A study aimed at improving the conduct and efficiency of trials by developing a standardised set of site performance metrics and a systematic approach to reporting
Sophie Betteridge
2017 (Liverpool) Annual Meeting
Contributed Session
A system for real-time integration of laboratory data into trials of targeted therapy with applications to Acute Myeloid Leukaemia
Rebecca Barnes
2017 (Liverpool) Annual Meeting
Contributed Session
A systematic mapping review of methods used for the evaluation of implementation fidelity in primary care trials
Sena Jawad
2017 (Liverpool) Annual Meeting
Contributed Session
A systematic review identifying neonatal core data elements for clinical trials, and assessment of data completeness of identified data elements using the National Neonatal Research Database (NNRD)
Richéal Burns
2017 (Liverpool) Annual Meeting
Contributed Session
A systematic review of analytical methods applied for discarded organs in kidney and liver transplantation research
Heather Catt
2017 (Liverpool) Annual Meeting
Contributed Session
A systematic review of core outcomes for Crohn's Disease in adults